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I.		Chapter	1:		Introduction		When	 breast	 cancer	 progression	 reaches	 its	 final	 metastatic	 stage,	 the	 disease	 is	considered	incurable.	While	considerable	advances	have	been	made	in	early	detection,	it	is	now	 believed	 that	 metastasis	 is	 an	 earlier	 step	 in	 tumor	 development	 than	 previously	thought,	thereby	making	it	very	difficult	to	prevent	(Balic	et	al.,	2006;	Dumont	et	al.,	2013).	Furthermore,	much	remains	unknown	about	 the	mechanisms	that	underlie	metastasis.	 In	the	past,	whole	genome	microarray	analysis	has	been	utilized	to	interrogate	patient	tumor	samples	 to	 identify	 transcriptional	 changes	 that	 occur	 as	 cells	 undergo	 tumorigenic	 and	metastatic	 progression	 in	 an	 effort	 to	 identify	 novel	 disease	 biomarkers.	 However,	 this	approach	has	yielded	limited	success,	likely	because	the	transcriptome	does	not	accurately	mirror	the	proteome.	There	are	several	layers	of	regulation	that	play	a	role	in	determining	whether	an	mRNA	transcript	 is	 translated	 into	protein.	Heterogeneous	ribonucleoprotein	E1	(HnRNP	E1)	is	an	RNA-binding	protein	that	is	known	to	function	in	regulation	of	mRNA	splicing,	transcription,	and	translation.	Previously,	we	characterized	the	role	of	hnRNP	E1	in	 translational	 regulation	 of	 mRNAs	 involved	 in	 TGFβ-mediated	 epithelial-to-mesenchymal	transition	(EMT)	(Chaudhury,	Hussey,	et	al.,	2010;	Hussey	et	al.,	2011).	Here,	we	 find	 that	 hnRNP	 E1	 regulates	 translation	 of	 mRNAs	 in	 a	 variety	 of	 other	 biological	processes	besides	EMT,	including	cell	cycle.	In	particular,	this	dissertation	investigates	the	hnRNP	E1-mediated	translational	regulation	of	expression	of	Cdc27,	a	core	component	of	the	anaphase-promoting	complex/cyclosome	(APC/C).	In	 normal	 cells,	 a	 tightly	 regulated	 system	 is	 in	 place	 that	 ensures	 precise	duplication	 and	 division	 of	 genetic	 material,	 maintaining	 the	 genome	 throughout	generations	of	cells.	Deregulation	of	cell	cycle	is	one	of	the	many	hallmarks	of	cancer	and	its	
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consequences	include	chromosomal	instability.		The	APC/C	is	an	E3	ubiquitin	ligase	whose	primary	 activity	 is	 ubiquitinating	 substrates	 involved	 in	 cell	 cycle	 progression,	 thereby	preventing	 premature	 S	 phase	 entry	 during	 G1	 and	 promoting	 anaphase	 during	mitosis.	Ineffective	 regulation	 of	 APC/C	 activity	 results	 in	 genomic	 instability:	 cells	 prematurely	enter	 S	 phase,	 resulting	 in	 DNA	 replication	 errors,	 or	 divide	 their	 DNA	 prior	 to	 proper	alignment	 and	 attachment	 during	 metaphase.	 The	 predisposition	 to	 chromosomal	aberrations	is	advantageous	for	cancer	cells,	as	they	are	better	able	to	adapt	to	changes	in	their	microenvironments	 such	 as	 nutrient	 fluctuation	 and	 hypoxia	 during	 the	multi-step	process	 of	 metastasis.	 Not	 only	 does	 chromosomal	 instability	 favor	 metastasis,	 it	 also	complicates	 the	 clinical	 treatment	 of	 the	 disease,	 as	 the	 tumors	 are	 phenotypically	heterogeneous	 and	 treatment-resistant	 subpopulations	 arise.	 It	 is	 therefore	 essential	 to	uncover	 the	mechanisms	 that	 underlie	 the	 regulation	 of	 chromosomal	 stability	 to	 better	understand	the	process	of	metastasis.		The	purpose	of	this	study	is	to	investigate	the	contribution	of	hnRNP	E1	to	cell	cycle	regulation,	 specifically	 through	 its	 post-transcriptional	 regulation	 of	 Cdc27	 expression.	Cdc27	 was	 identified	 in	 a	 screen	 of	 transcripts	 that	 were	 translationally	 upregulated	 in	hnRNP	E1-null	 cells.	 First,	we	 validate	 the	 translational	 upregulation	 of	 Cdc27	 in	 hnRNP	E1-knockdown	 cells.	 Then,	 we	 explore	 hnRNP	 E1-mediated	 regulation	 of	 Cdc27	 mRNA	translation	 during	 the	 cell	 cycle.	 We	 proceed	 by	 identifying	 the	 kinase	 responsible	 for	hnRNP	 E1	 phosphorylation,	 which	 modulates	 its	 binding	 to	 Cdc27	 mRNA.	 The	 role	 of	constitutive	 expression	 of	 Cdc27	 is	 assessed	 with	 regard	 to	 APC/C	 function	 and	chromosomal	instability.	Finally,	the	relevance	of	Cdc27	in	human	breast	cancer	cell	 lines	and	 patient	 samples	 is	 addressed.	 Based	 on	 previous	 results	 and	 preliminary	 data,	 we	
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propose	 that	hnRNP	E1	acts	as	a	 tumor	suppressor	and	 loss	of	 its	 translational	 silencing	function	through	increased	proliferative	signaling	leads	to	aberrant	expression	of	cell	cycle	proteins	 involved	 in	 acquisition	 of	 a	 pro-metastatic	 phenotype.	 The	 use	 of	 cultured	 cell	lines	presents	limitations	when	studying	human	disease.	We	have	attempted	to	reduce	the	effect	of	these	limitations	by	repeating	in	vitro	experiments	in	human	cell	lines,	as	well	as	analyzing	patient	samples	and	data.	In	summary,	we	explore	the	mechanisms	upstream	of	Cdc27	 translational	 regulation	 and	 downstream	 of	 constitutive	 Cdc27	 expression	 in	 the	context	of	breast	cancer	progression.		In	our	previous	studies,	we	focused	on	the	role	of	heterogeneous	ribonucleoprotein	E1	in	TGFβ-dependent	translational	silencing	in	the	process	of	epithelial-to-mesenchymal	transition	(EMT)	(Chaudhury,	Hussey,	et	al.,	2010;	Howley	et	al.,	2015;	Hussey	et	al.,	2011;	Hussey	et	al.,	2012).	Normal	murine	mammary	gland	cells	(NMuMG)	were	used,	as	they	are	an	established	model	cell	line	for	studying	TGFβ-induced	EMT	(Moustakas	&	Heldin,	2005;	Zavadil	&	Bottinger,	2005).	To	generate	a	list	of	mRNAs	that	were	translationally	silenced	by	 hnRNP	E1,	 and	 then	 actively	 translated	 upon	 stimulation	with	 TGFβ,	 a	 combinatorial	method	was	employed	using	both	polysome	profiling	and	Affymetrix	array	analysis.	Briefly,	NMuMGs,	NMuMGs	treated	with	TGFβ,	and	NMuMGs	in	which	hnRNP	E1	had	been	stably	silenced	(E1KDs)	were	subject	to	polysome	profiling	followed	by	Affymetrix	array	analysis.	NMuMG	and	E1KD	cells	were	synchronized	by	culturing	in	low	serum	medium	overnight.	To	 validate	 the	 synchronization,	 cell	 cycle	 profiles	 were	 obtained	 by	 propidium	 iodide	staining	followed	by	flow	cytometric	analysis	of	total	DNA	content	in	cells.	When	analyzing	a	 population	 of	 cells	 for	 cell	 cycle	 phase	 by	 propidium	 iodide	 staining,	 one	 will	 usually	obtain	two	distinct	peaks	in	a	histogram	with	the	propidium	iodide	staining	on	the	x-axis.	
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The	 first	 peak	 represents	 the	 G1	 population	 and	 the	 DNA	 content	 is	 said	 to	 be	 2N.	 The	second	peak	should	correspond	to	a	number	on	the	x-axis	that	is	double	the	number	under	the	 first	G1	peak.	This	peak	corresponds	 to	 the	G2/M	population	and	 the	DNA	content	 is	said	to	be	4N.	Any	cells	that	exhibit	an	intermediate	DNA	content	between	2N	and	4N	are	progressing	through	S	phase.	Polysome	 profiling	 involves	 the	 sedimentation	 of	 cytosolic	 extracts	 from	 cells,	separating	 the	 less	 dense	 fractions	 from	 the	 more	 dense	 fractions.	 When	 collecting	fractions	from	the	sucrose	gradient	after	ribosome	sedimentation,	 the	absorbance	is	read	at	254	nm.	This	absorbance	value	is	then	plotted	on	a	graph	versus	fraction	number.	The	absorbance	 corresponds	 to	 the	 ribosomal	 RNA	 in	 the	 sample,	 and	 allows	 for	 the	assignment	of	monosome	or	polysome	 to	 fractions.	The	highest	peak	 corresponds	 to	 the	complete	 80S	 ribosome,	 and	 any	 fractions	 lighter	 than	 and	 including	 the	 80S	 are	considered	monosomal,	 and	 those	 heavier	 than	 the	 80S	 are	 considered	 polysomal.	 After	collecting	 the	 individual	 fractions,	 total	 RNA	 is	 isolated	 and	 analyzed	 by	 RNA	electrophoresis	to	determine	the	 identity	of	the	fractions.	Because	ribosomal	RNA	is	very	abundant,	 it	 is	 easily	 detectable	 by	 agarose	 gel	 electrophoresis	 and	 ethidium	 bromide	staining.	The	differential	distribution	of	the	18S	and	28S	rRNA	in	the	fractions	reveals	the	presence	 of	 40S,	 60S,	 or	 80S	 ribosomal	 subunits.	 The	 mRNA	 isolated	 from	 the	 dense	fractions	 is	 considered	 actively	 translating,	 polysomal	 mRNA	 because	 of	 its	 association	with	more	 than	 one	 ribosome.	 The	mRNA	 isolated	 from	 the	 light	 fractions	 is	 considered	translationally	silent	or	weak,	as	it	is	only	present	in	fractions	containing	only	40S	or	60S	ribosomal	 translation	 complexes.	 The	 RNA	 isolated	 from	 monosomal	 and	 polysomal	fractions	 was	 then	 transcribed	 into	 complementary	 DNA	 (cDNA)	 and	 hybridized	 to	 an	
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Affymetrix	array	chip.	The	cDNA	synthesis	and	Affymetrix	array	analysis	was	performed	by	the	Medical	University	of	South	Carolina	Proteogenomics	Facility.		The	results	of	the	previous	Affymetrix	array	analysis	allowed	for	the	 identification	of	 a	 group	 of	 mRNAs	 whose	 translation	 was	 both	 TGFβ-	 and	 hnRNP	 E1-dependent,	previously	termed	“BAT”	genes,	for	TGFβ-activated	translation	genes	(Chaudhury,	Hussey,	et	 al.,	 2010;	 Hussey	 et	 al.,	 2011;	 Hussey	 et	 al.,	 2012).	 While	 this	 study	 yielded	 many	interesting	 TGFβ-sensitive	 hnRNP	 E1	 targets	 of	 translational	 regulation	 including	 Dab2,	ILEI,	 and	 Inhibin	β-A,	 there	were	yet	a	 large	number	of	mRNAs	 that	were	 translationally	silent	 in	 NMuMGs	 and	 active	 in	 E1KDs,	 independent	 of	 TGFβ.	 Furthermore,	 some	preliminary	 data	with	 E1KD	 cells	 revealed	 that	 they	were	more	 invasive	 and	 aggressive	than	 NMuMGs	 treated	 with	 TGFβ,	 suggesting	 that	 hnRNP	 E1	 was	 regulating	 processes	downstream	of	other	stimuli	besides	TGFβ.			
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II.	Chapter	2:		Review	of	Literature	
Assessing	 mRNA	 translation	 Affymetrix	 and	 microarray	 technologies	 have	recently	 achieved	 popularity	 as	 methods	 for	 high-throughput	 screening	 of	 biological	samples	to	analyze	mRNA	expression	in	an	effort	to	curate	disease-specific	gene	signatures.	It	was	hoped	that	these	gene	signatures	would	aid	in	identifying	novel	disease	biomarkers	to	 facilitate	 patient	 stratification	 and	 assignment	 of	 therapeutic	 strategies.	 However,	attempts	 to	 correlate	 mRNA	 expression	 with	 relative	 protein	 abundance	 have	 yielded	variable	 results,	 as	 it	 became	 evident	 that	 the	 proteome	 did	 not	 accurately	 mirror	 the	transcriptome	 (Ghazalpour	et	 al.,	 2011;	 Schwanhausser	et	 al.,	 2011).	Post-transcriptional	regulation	plays	a	major	role	 in	 the	determination	of	 the	 fate	of	messenger	RNAs,	so	 it	 is	not	surprising	that	specific	mRNA	abundance	did	not	accurately	reflect	the	level	of	protein.	The	 methods	 currently	 available	 for	 proteomic	 profiling	 include	 two-dimensional	 gel	electrophoresis	 and	mass	 spectrometry,	 both	 of	which	 are	 labor-intensive	 and	 require	 a	high	level	of	expertise.	In	order	to	better	assess	the	relationship	between	mRNA	expression	and	protein	abundance,	we	decided	to	utilize	polysome	profiling.	Polysome	profile	analysis	provides	an	attractive	alternative,	in	that	it	is	relatively	simple	and	inexpensive,	and	offers	a	more	accurate	perspective	on	the	level	of	protein	expression	based	on	the	efficiency	with	which	 its	mRNA	 is	 being	 translated.	 Described	 previously	 by	Merrick	 et	 al.,	 this	method	allows	for	the	 linear	separation	of	RNA	based	on	its	density,	 in	direct	correlation	with	 its	association	with	ribosomal	subunits	(Merrick	&	Hensold,	2001).	Combined	with	Affymetrix	array	 analysis,	 polysome	 profiling	 is	 a	 powerful	 technique	 that	 allows	 identification	 of	transcripts	based	on	their	differential	translational	efficiency.	This	is	a	better	predictor	of	protein	 expression	 than	 Affymetrix	 array	 analysis	 alone,	 but	 is	 not	 without	 limitations.	
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Polysome	 profiling	 does	 not	 account	 for	 post-translational	 modifications	 that	 affect	 the	stability	of	proteins,	and	so	must	be	validated	by	other	protein-detection	techniques.		Regulation	of	mRNA	expression	at	the	translational	level	offers	a	distinct	advantage	to	cells:	response	to	intra-	and	extracellular	cues	can	be	mediated	swiftly	in	the	presence	of	a	pre-transcribed	mRNA,	without	 the	need	 to	 first	 transcribe	a	gene.	This	adaptation	 is	a	valuable	 tool	 that	may	 be	 exploited	 by	 cancer	 cells,	 as	 they	 have	 an	 increased	 need	 for	adaptability	during	the	multistep	process	of	metastasis	as	they	proceed	from	one	locale	to	the	 next	 (Silvera,	 Formenti,	 &	 Schneider,	 2010).	 Furthermore,	 translational	 regulation	 of	mRNA	expression	is	necessary	during	normal	cellular	development,	as	transcription	does	not	occur	immediately	in	the	embryo	and	maternal	mRNA	translation	must	be	regulated	in	a	 spatiotemporal	 manner	 (Kronja	 &	 Orr-Weaver,	 2011).	 A	 central	 theme	 exists	 in	translational	 regulation,	 and	 that	 is	 the	 recognition	 of	 3’	 untranslated	 regions	 (UTRs)	 of	mRNAs	 by	 RNA-binding	 proteins	 or	 microRNAs,	 whose	 interaction	 serves	 to	 repress	 or	activate	translation	(Baker	&	Coller,	2006).		
Heterogeneous	 ribonucleoprotein	 E1	 and	 regulation	 of	 translation	Heterogeneous	 ribonucleoproteins	 represent	 a	 multifunctional	 family	 of	 RNA-binding	proteins	 that	 form	 hnRNP	 complexes	 and	 regulate	 a	 variety	 of	 post-transcriptional	 RNA	processes	 including	mRNA	 stability	 and	 translation,	 as	well	 as	 subcellular	 localization	 of	RNA	 (Chaudhury,	 Chander,	&	Howe,	 2010).	Heterogeneous	nuclear	 ribonucleoprotein	E1	(hnRNP	E1),	in	particular,	is	ubiquitously	expressed	and	has	been	shown	to	regulate	some	aspects	of	mRNA	biology	including	mRNA	stability	and	translational	regulation	(Meng	et	al.,	2007;	Ostareck	et	al.,	1997;	Ostareck-Lederer,	Ostareck,	&	Hentze,	1998).	The	mechanisms	described	 for	hnRNP	E1-mRNA	 interaction	 follow	 the	 canonical	 architecture	 set	 forth	by	
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other	RNA-binding	proteins,	in	that	hnRNP	E1	has	been	shown	to	localize	to	3’	UTRs	of	its	target	genes.	HnRNP	E1	was	described	in	its	role	as	a	repressor	of	15-lipoxygenase	mRNA	translation	 during	 red	 blood	 cell	 maturation.	 A	 regulatory	 motif,	 termed	 “DICE”	 for	differentiation	control	element,	was	identified	in	the	3’	UTR	of	15-lipoxygenase	mRNA,	and	it	was	shown	that	hnRNP	E1	interacted	with	this	element,	silencing	translation	until	late	in	erythropoiesis	(Ostareck	et	al.,	1997;	Ostareck-Lederer,	Ostareck,	Standart,	&	Thiele,	1994).	Others	described	 the	contribution	of	hnRNP	E1	binding	 to	 the	3’	UTR	of	α-globin	mRNA,	stabilizing	it	by	attenuating	deadenylation	during	erythrocyte	production	(Morales,	Russell,	&	Liebhaber,	1997;	Weiss	&	Liebhaber,	1994).	The	mechanisms	by	which	hnRNP	E1	had	been	shown	to	bind	and	regulate	mRNA	provided	a	scaffold	upon	which	the	TGFβ-mediated	“BAT”	mechanism	was	later	modeled	(Chaudhury,	Hussey,	et	al.,	2010).		Through	a	series	of	experiments,	Hussey	et	al.	identified	an	mRNP	complex	wherein	hnRNP	E1,	along	with	elongation	 factor	1	alpha	1	 (EF1A1),	act	as	 trans	factors	 to	silence	translation	by	binding	the	3’	untranslated	region	(UTR)	of	mRNAs	containing	a	specific	cis	regulatory	 element	 that	 was	 termed	 “BAT”	 for	 TGFβ-activated	 translation.	 Translational	silencing	conferred	by	hnRNP	E1	could	be	relieved	by	transforming	growth	factor	β	(TGFβ)	stimulation,	through	noncanonical	activation	of	the	PI3K	signaling	pathway,	resulting	in	the	Akt2-dependent	 phosphorylation	 of	 hnRNP	 E1	 at	 its	 serine	 43	 residue.	 This	phosphorylation	event	was	sufficient	to	abrogate	translational	silencing	of	Dab2	and	ILEI,	two	EMT-inducer	transcripts.	The	observed	increase	in	the	abundance	of	disabled-2	(Dab2)	and	interleukin-like	EMT-inducer	(ILEI)	occurred	without	a	concomitant	increase	in	mRNA	expression,	supporting	the	model	that	the	increase	in	expression	observed	was	a	result	of	
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post-transcriptional	 gene	 control	 (Chaudhury,	 Hussey,	 et	 al.,	 2010;	 Hussey	 et	 al.,	 2011;	Hussey	et	al.,	2012).		Stable	 knockdown	 of	 hnRNP	 E1	 expression	 in	 normal	 murine	 mammary	 gland	(NMuMG)	cells	resulted	not	only	in	the	increase	in	Dab2	and	ILEI	expression,	but	also	in	the	acquisition	of	a	mesenchymal	phenotype	 in	vitro	characterized	by	a	gain	of	mesenchymal	cell	markers	and	a	loss	of	epithelial	cell	markers	(Chaudhury,	Hussey,	et	al.,	2010),	and	in	
vivo	 characterized	 by	 acquisition	 of	 invasive	 and	 metastatic	 capabilities	 (Howley	 et	 al.,	2015).	 To	 further	 investigate	 the	 scope	 of	 hnRNP	 E1-mediated	 translational	 control,	 a	combinatorial	approach	involving	differential	gene	expression	profiling	and	transcriptomic	analysis	was	utilized:	 	Affymetrix	array	analysis	was	performed	on	cDNA	generated	 from	the	monosomal	or	polysomal	RNA	of	NMuMG	and	E1KD	cells	(Hussey	et	al.,	2012).	In	brief,	differential	 sedimentation	was	 used	 to	 separate	 dense,	 ribosome-rich	mRNA	 (polysome)	fractions	 from	 light,	 ribosome-poor	 mRNA	 (monosome)	 fractions.	 RNA	 isolated	 from	distinct	 fractions	 was	 reverse	 transcribed,	 and	 then	 the	 cDNA	 generated	was	 subject	 to	Affymetrix	 array	 analysis	 to	 identify	 genes	 that	 are	 constitutively	 expressed	 in	 the	polysomal	fractions	of	E1KDs,	while	they	remained	in	the	monosomal	fractions	of	NMuMG	controls.	While	the	initial	purpose	of	the	experiment	was	to	identify	genes	that	were	both	hnRNP	E1-	and	TGFβ-dependent,	there	were	a	large	number	of	genes	that	appeared	to	be	regulated	by	hnRNP	E1	independent	of	TGFβ.	
Phosphorylation	 of	 hnRNP	 E1	 and	 its	 effect	 on	 translational	 silencing	Phosphorylation	of	heterogeneous	ribonucleoproteins	has	been	said	to	impact	their	affinity	for	RNA	(Dreyfuss,	Matunis,	Pinol-Roma,	&	Burd,	1993).	Previously,	our	research	focused	on	TGFβ-induced	activation	of	Akt2	and	its	phosphorylation	of	hnRNP	E1.	However,	a	large	
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number	of	hnRNP	E1-regulated	genes	identified	in	our	screen	were	not	influenced	by	TGFβ,	and	that	led	us	to	investigate	other	possible	upstream	modulators	of	hnRNP	E1	function.	It	has	 been	 previously	 reported	 by	 others	 that	 p21-activated	 kinase	 1	 (Pak1)	 can	phosphorylate	 hnRNP	 E1,	 abrogating	 its	 binding	 to	 a	 3’	 UTR	 cis	 regulatory	 element	 in	L1CAM	 mRNA.	 HnRNP	 E1	 could	 successfully	 silence	 in	 vitro	 translation	 of	 a	 synthetic	reporter	 gene	 with	 the	 L1CAM	 DICE	 element	 cloned	 downstream	 (Meng	 et	 al.,	 2007).	Because	of	 this,	 Pak1	was	 considered	 early	 on	 as	 an	 alternative	 candidate	 for	hnRNP	E1	phosphorylation	 in	 the	 context	of	 translational	 repression.	Pak1	 is	normally	 activated	by	the	small	GTPases	Cdc42	and	Rac	(Viaud	&	Peterson,	2009),	however	one	of	the	hallmarks	of	 cancer	 is	 sustained	 proliferative	 signaling	 without	 the	 need	 for	 exogenous	 growth	stimuli	(Hanahan	&	Weinberg,	2000,	2011).	Furthermore,	constitutive	Pak1	activation	is	a	prevalent	 characteristic	 in	 many	 types	 of	 cancer	 (Wang,	 Zhang,	 Balasenthil,	 Medina,	 &	Kumar,	 2006).	 Identifying	 downstream	 targets	 of	 Pak1	 activation	 would	 be	 a	 valuable	finding	in	revealing	cellular	pathways	that	are	exploited	by	cancer	cells.		
Translational	 regulation	 of	 Cdc27	 expression	 The	 goal	 of	 this	 research	 is	 to	elucidate	 the	 extent	 to	 which	 hnRNP	 E1	 is	 involved	 in	 cell	 cycle	 regulation	 through	translational	 silencing	 of	 a	 subset	 of	 cell	 cycle-related	 mRNAs.	 Through	 the	 previously	mentioned	 screen	 of	 hnRNP	 E1-regulated	 genes,	 we	 investigate	 cell	 division	 cycle	 27	(Cdc27),	 an	 mRNA	 encoding	 for	 a	 core	 subunit	 of	 the	 anaphase-promoting	complex/cyclosome	(APC/C).	HnRNP	E1-mediated	regulation	of	Cdc27	translation	has	not	been	previously	 reported.	 The	APC/C	 is	 a	 large,	multi-subunit	 E3	ubiquitin	 ligase	 that	 is	responsible	 for	 ubiquitinating	 cell	 cycle	 proteins	 for	 proteasome-mediated	 degradation	(Peters,	2002,	2006).	The	careful	regulation	of	APC/C	activity	is	critical	in	order	to	prevent	
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premature	 ubiquitination	 of	 substrates	 such	 as	 securin	 and	 cyclin	 B1	 (Listovsky	 &	 Sale,	2013;	Prosser,	Samant,	Baxter,	Morrison,	&	Fry,	2012).	It	has	been	shown	that	premature	activation	of	 the	APC/C	can	 lead	to	metaphase	arrest,	sometimes	resulting	 in	centrosome	amplification	and	aneuploid	cell	division	(Eytan,	Sitry-Shevah,	Teichner,	&	Hershko,	2013;	Listovsky	&	Sale,	2013;	Prosser	et	al.,	2012).	Previous	research	has	focused	on	the	role	of	the	mitotic	checkpoint	complex	(MCC)	in	regulating	APC/C	function	during	mitosis	(Penas,	Ramachandran,	&	Ayad,	2011;	Sudakin,	Chan,	&	Yen,	2001;	Tipton	et	al.,	2011),	wherein	the	MCC	 functions	 to	 sequester	 the	 APC/C-activating	 cofactor,	 Cdc20,	 prior	 to	 proper	chromosome-microtubule	attachment	at	the	metaphase	plate.	Because	of	its	identification	as	 an	 hnRNP	 E1-regulated	 mRNA,	 we	 investigate	 the	 contribution	 of	 Cdc27	 to	 the	metastatic	phenotype	exhibited	by	hnRNP	E1-knockdown	cells.		
Cdc27	 function	 in	 APC/C	 and	 cell	 cycle	 regulation	 Cdc27	 is	 one	 of	 thirteen	subunits	that	comprise	the	eukaryotic	anaphase	promoting	complex/cyclosome,	a	large	E3	ubiquitin	ligase	that	targets	specific	proteins	for	degradation	during	the	cell	cycle	(Peters,	2002).	Of	the	core	subunits,	Cdc27	is	unique	in	that	it	directly	associates	with	either	of	two	cofactors	 that	 govern	 the	 specificity	 of	 the	 APC/C	 ubiquitin	 ligase,	 Cdh1	 or	 Cdc20.	 The	APC/CCdh1	is	active	during	late	mitosis	through	G1	phase,	whereas	the	APC/CCdc20	is	active	only	during	anaphase.	The	APC/CCdc20	is	normally	inhibited	until	the	cell	senses	that	sister	chromatids	are	properly	aligned	at	the	metaphase	plate	and	all	kinetochores	are	attached	to	microtubules	 of	 the	mitotic	 spindle.	Only	 then	 is	 the	APC/CCdc20	 activated	 and	 securin	and	cyclin	B	are	degraded,	allowing	for	the	metaphase-to-anaphase	transition	and	for	the	genetic	material	of	the	cell	to	be	divided	evenly	(Kramer,	Scheuringer,	Podtelejnikov,	Mann,	&	Peters,	2000;	Peters,	2002,	2006).	The	mitotic	checkpoint	complex	(MCC)	is	responsible	
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for	 inhibiting	APCCdc20	activity	by	sequestering	Cdc20	during	mitosis	until	bipolar	spindle	attachment	 has	 been	 achieved	 (Sudakin	 et	 al.,	 2001;	 Tipton	 et	 al.,	 2011).	 Here	 we	investigate	 the	 consequences	 of	 constitutive	 expression	 of	 Cdc27	 resulting	 from	 loss	 of	hnRNP	E1-mediated	translational	silencing.		Previously,	 others	 have	 investigated	 the	 expression	 of	 Cdc27	 in	 breast	 cancer.	Pawar	 et	 al.	 concluded	 that	 Cdc27	might	 act	 as	 a	 tumor	 suppressor	 by	 inducing	 APC/C-dependent	 degradation	 of	 Cyclin	D1.	 They	 report	 that	 the	 transcription	 factor,	 CEBPδ,	 is	responsible	for	increased	Cdc27	transcription	in	mouse	embryonic	fibroblasts,	and	that	this	increase	 in	Cdc27	 is	responsible	 for	directing	Cyclin	D1	to	alternative	degradation	by	the	APC/C.	Furthermore,	they	show	an	overall	decrease	in	Cdc27	expression	in	breast	cancer	cell	 lines	 (Pawar	 et	 al.,	 2010).	 The	 results	 reported	 in	 this	 dissertation	 do	 not	 align	precisely	with	those	reported	by	Pawar	et	al.,	however	that	may	be	a	result	of	their	focus	on	 the	 transcriptional	 regulation	 of	Cdc27	 in	 response	 to	 the	 transcription	 factor	 CEBPδ	rather	 than	 focusing	 on	 translational	 regulation.	 	 Importantly,	 the	 finding	 that	 increased	Cdc27	expression	can	lead	to	redirection	of	SCF	substrates	to	the	APC/C	is	consistent.		
Aberrant	 APC/C	 activity	 in	 cancer	 Proper	 APC/C	 activity	 has	 previously	 been	shown	 to	 be	 necessary	 for	 the	 maintenance	 of	 genomic	 integrity	 (Garcia-Higuera	 et	 al.,	2008;	 Penas	 et	 al.,	 2011).	 Temporal	 regulation	 of	 protein	 ubiquitination	 and	 subsequent	degradation	 allows	 the	 forward-only	 progression	 through	 the	 cell	 cycle,	 prevents	 re-duplication	 of	 DNA,	 and	 ensures	 that	 duplicated	 chromosomes	 are	 divided	 perfectly	equally	between	daughter	cells	prior	to	cytokinesis	(Penas	et	al.,	2011;	Peters,	2006).	Due	to	 its	 extensive	 role	 in	 regulating	 cell	 cycle	 progression,	 it	 is	 obvious	 that	 maintaining	proper	 APC/C	 activity	 through	 regulation	 of	 its	 activating	 cofactors	 is	 essential	 to	
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maintaining	 chromosomal	 stability.	 Premature	 activation	 of	 the	 APC/C	 during	 mitosis	results	in	mitotic	aberrations	such	as	lagging	chromosomes	and	anaphase	bridges,	both	of	which	can	result	 in	aneuploid	chromosome	numbers	(Listovsky	&	Sale,	2013).	Premature	activation	of	the	APC/CCdc20	during	G1	leads	to	premature	S	phase	entry	and	degradation	of	APC/C	target,	geminin,	which	can	result	in	DNA	re-replication	(Clijsters,	Ogink,	&	Wolthuis,	2013).			Others	 have	 reported	 on	 contribution	 of	 phosphorylation	 to	 the	 affinity	 of	 APC/C	core	 components	 and	 cofactors.	 Several	 APC/C	 core	 subunits	 are	 phosphorylated	 during	mitosis,	 and	 this	 phosphorylation	was	 shown	 to	 increase	 ubiquitin	 ligase	 activity	 of	 the	complex	(Kramer	et	al.,	2000).	Phosphorylation	of	the	cofactor,	Cdc20,	was	also	shown	to	enhance	its	binding	to	the	core	complex;	in	contrast,	the	phosphorylation	of	Cdh1	ablated	its	ability	to	bind	to	the	APC/C	(Kramer	et	al.,	2000).	Atypical	kinase	activity	is	often	seen	in	cancer,	 and	 might	 contribute	 to	 the	 overall	 ability	 of	 the	 APC/C	 to	 ubiquitinate	 targets	appropriately.	We	do	not	 investigate	the	phosphorylation	of	the	APC/C	components	here,	but	 recognize	 the	 regulatory	 role	 that	 phosphorylation	 plays	 in	 combination	 with	translational	regulation	of	Cdc27.		
Cdh1	deletion	results	in	genomic	instability	and	tumorigenesis	Cdh1	has	been	described	 previously	 as	 a	 tumor	 suppressor,	 and	 is	 implicated	 in	 both	 centrosome	amplification	and	missegregation	of	chromosomes	(Garcia-Higuera	et	al.,	2008).	Levels	of	Cdh1	are	normally	regulated	during	the	cell	cycle	by	ubiquitination	by	the	Skp1/Cullin/F-box	 (SCF)	E3	ubiquitin	 ligase	 (Benmaamar	&	Pagano,	2005;	Fukushima	et	al.,	2013).	The	SCF	is	constitutively	active,	its	specificity	dictated	by	the	presence	of	different	cofactors	and	the	 recognition	 of	 phosphorylated	 residues,	 or	 phosphodegrons,	 of	 its	 substrates	
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(Fukushima	et	al.,	2013).	Thus,	the	careful	regulation	of	Cdh1	phosphorylation	is	necessary	to	guarantee	that	it	is	not	ubiquitinated	and	degraded	in	an	untimely	fashion.	The	cofactor	responsible	 for	 Cdh1	 recognition	 by	 the	 SCF	 is	 beta-transducin	 repeating-containing	protein	 (β-TRCP)	 which	 recognizes	 phosphodegrons	 on	 Cdh1	 after	 it	 has	 been	phosphorylated	 by	 cyclin-dependent	 kinase	 1	 (CDK1)	 and	 polo-like	 kinase	 1	 (Plk1)	(Fukushima	et	al.,	2013).	As	previously	mentioned,	proliferative	signaling	in	the	absence	of	growth	stimuli	commonly	occurs	during	 tumor	progression	(Hanahan	&	Weinberg,	2000,	2011),	 and	 this	 sustained	 proliferative	 signaling	 can	 lead	 to	 activation	 of	 downstream	signaling	 pathways.	 We	 consider	 the	 role	 of	 constitutive	 activation	 of	 the	 kinases	responsible	for	Cdh1	phosphorylation	and	recognition	by	the	SCF	in	this	study,	as	well	as	the	degradation	of	other	SCF	substrates.	We	also	consider	alternative	degradation	of	Cdh1	by	the	APC/C,	much	like	the	reported	APC/C-dependent	degradation	of	Cyclin	D1	(Pawar	et	al.,	2010).	Loss	of	Cdh1-mediated	APC/C	activity	results	 in	errors	 in	DNA	replication	and	ultimately	contributes	to	aneuploidy	(Engelbert,	Schnerch,	Baumgarten,	&	Wasch,	2008).		
Chromosomal	 instability	Chromosomal	instability	is	the	term	used	to	describe	an	increased	rate	in	missegregation	of	chromosomes	during	cell	division,	often	resulting	in	net	gains	 or	 losses	 in	 total	 chromosome	 number,	 or	 aneuploidy.	 Approximately	 90%	 of	carcinomas	 exhibit	 aneuploid	 chromosome	 numbers	 (Weaver	 &	 Cleveland,	 2006).	Susceptibility	to	chromosomal	instability	is	a	valuable	adaptation	acquired	by	cancer	cells	in	that	they	exhibit	accelerated	rates	of	evolution,	conferring	increased	adaptability	to	new	and	 changing	 microenvironments	 (Heng	 et	 al.,	 2013).	 Additionally,	 errors	 in	 cell	 cycle	checkpoints	often	accompany	chromosomal	instability,	allowing	cells	with	DNA	damage	or	aneuploidy	 to	 avoid	 cell	 cycle	 arrest	 and	 continue	proliferating	 (Bharadwaj	&	Yu,	 2004).	
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The	mechanisms	 underlying	 chromosomal	 instability	 remain	 poorly	 understood.	 That	 is,	while	 some	 causes	 of	 chromosomal	 instability	 have	 been	 identified,	 such	 as	 errors	 in	spindle	 assembly	 checkpoint,	 centrosome	 duplication,	 and	 bipolar	 spindle	 attachment	(Bakhoum	 &	 Compton,	 2012;	 Heng	 et	 al.,	 2013;	 Nowak	 et	 al.,	 2002),	 the	 mechanisms	underlying	their	regulation	have	not	been	elucidated.	The	role	of	the	APC/C	in	regulating	proper	 chromosomal	 segregation	 and	 initiation	 of	 DNA	 replication	 underpins	 its	importance	 in	 maintaining	 the	 genomic	 integrity	 of	 cells.	 We	 evaluate	 the	 variable	expression	 of	 APC/C	 core	 component,	 Cdc27,	 in	 both	 breast	 cancer	 cell	 lines	 and	 breast	cancer	 patient	 samples	 in	 an	 attempt	 to	 correlate	 it	 with	 chromosomal	 instability	 and	metastatic	recurrence.		
In	 vivo	 selection	 of	 cells	 that	 metastasize	 to	 lung	 In	 the	 past,	 others	 have	described	 a	 method	 for	 in	 vivo	 selection	 of	 cells	 that	 metastasize	 to	 specific	 organs	 by	passaging	them	in	mice	(Bos	et	al.,	2009;	Minn	et	al.,	2005).	The	purpose	of	developing	such	a	 model	 is	 to	 assess	 the	 genetic	 changes	 that	 cells	 undergo	 as	 they	 progress	 from	 the	primary	 tumor	 site	 to	 distant	metastases.	 Organ-specific	 gene	 signatures	were	 assigned,	with	the	intent	of	identifying	novel	disease	biomarkers	(Bos	et	al.,	2009;	Minn	et	al.,	2005).	This	 and	 other	 studies	 utilizing	 in	vivo	 selection	 techniques	 have	 relied	 upon	 cancer	 cell	lines	 that	have	already	 transitioned	 from	normal	 to	malignant	 cells.	With	 this	method	 in	mind,	 our	 laboratory	 has	 developed	 a	 mouse	 model	 of	 metastasis	 utilizing	 the	 non-transformed	 mouse	 mammary	 gland	 epithelial	 (NMuMG)	 cell	 line.	 We	 have	 shown	 that	knockdown	of	the	RNA	binding	protein	hnRNP	E1,	a	known	regulator	of	the	epithelial-to-mesenchymal	transition,	results	in	the	ability	of	hnRNP	E1	knockdown	cells	(E1KD)	to	form	tumors	 and	distant	metastases	 in	vivo	when	 injected	 into	 the	mammary	 fat	pads	of	 SCID	
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mice	(Chaudhury,	Hussey,	et	al.,	2010;	Hussey	et	al.,	2011).	In	vivo	passaging,	which	allows	for	the	artificial	selection	of	cells	capable	of	forming	primary	tumors	and	lung	metastases,	can	 enhance	 the	 metastatic	 potential	 of	 the	 E1KD	 cell	 line.	 This	 technique	 led	 to	 the	isolation	 of	 two	 increasingly	 aggressive	 metastatic	 cell	 lines,	 termed	 L1P,	 and	 L2P,	 that	metastasize	to	 lung.	 In	addition,	 the	M1P	cell	 line	was	 isolated	from	a	primary	mammary	tumor.	 We	 believe	 that	 we	 have	 a	 unique	 model	 system	 for	 interrogating	 changes	associated	with	tumor	initiation	and	metastatic	progression:	 	while	previous	models	have	utilized	cancer	cell	lines	to	initiate	primary	tumors,	our	model	originates	from	normal,	non-metastatic	cell	line.			
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III.		Chapter	3:		Methods	
Reagents	 Primary	 antibodies:	 	 Mouse	 α-Fzr1,	 α-Cdc27,	 α-Securin,	 and	 α-Pak1	antibodies	were	obtained	from	Abcam.	Mouse	α-PCBP1	was	obtained	from	Abnova.	Rabbit	
α-APC3,	α-phospho-Pak1	 (Thr423),	α-Cdc20,	 HRP-conjugated	α-phospho-RXXS*/T*,	 and	Alexa	fluor	488-conjugated	α-alpha	tubulin	were	obtained	from	Cell	Signaling	Technology.	Mouse	 α-Hsp90,	 α-GAPDH,	 α-Cyclin	 A,	 goat	 α-L1CAM,	 and	 α-HnRNP	 E1	 were	 obtained	from	Santa	Cruz	Biotechnology.		Secondary	 antibodies:	 	 HRP-linked	 sheep	 α-mouse	 and	 donkey	 α-rabbit	 were	obtained	 from	 GE	 Healthcare	 Life	 Sciences,	 and	 HRP-linked	 rabbit	α-goat	 was	 obtained	from	Thermo	Scientific.		
Cell	culture	and	treatments	Cells	were	maintained	in	tissue	culture	incubators	at	37°C,	 5%	 CO2,	 and	 95%	 humidity.	 Normal	 murine	 mammary	 gland	 epithelial	 (NMuMG)	cells	 obtained	 from	 American	 Type	 Culture	 Collection	 (ATCC;	 Manassas,	 VA,	 USA)	 were	maintained	 in	Dulbecco’s	modified	Eagle’s	medium	 supplemented	with	 10%	 fetal	 bovine	serum	(Atlanta	Biologicals;	Atlanta,	GA,	USA),	10	µg/ml	insulin	(Lonza;	Allendale,	NJ,	USA),	and	antibiotics/antimycotics	(100	units/ml	penicillin	G,	100	mg/ml	streptomycin,	and	0.25	mg/ml	 amphotericin	 B)	 (Gibco/ThermoFisher;	 Grand	 Island,	 NY,	 USA).	 Puromycin	 was	purchased	 from	 Sigma-Aldrich	 (St.	 Louis,	 MO,	 USA)	 and	 neomycin	 (G418)	 was	 obtained	from	 Invivogen	 (San	 Diego,	 CA,	 USA).	 Stable	 hnRNP	 E1-knockdown	 (E1KD)	 cells	 were	generated	 in	 the	 laboratory	 by	 transfecting	 NMuMG	 cells	 with	 pSilencer	 2.1-U6	(Ambion/ThermoFisher;	 Grand	 Island,	 NY,	 USA)	 plasmid	 containing	 shRNA	 targeting	hnRNP	E1	and	a	puromycin	resistance	selection	marker.	E1KD	cells	were	maintained	in	the	same	 media	 as	 NMuMGs	 supplemented	 with	 10	 µg/ml	 puromycin.	 NMuMG-Cdc27	 cells	
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were	 generated	 in	 the	 laboratory	 by	 transfecting	 NMuMG	 cells	 with	 pECE-M2	 plasmid	containing	 the	 Cdc27	 open	 reading	 frame.	 NMuMG-Cdc27	 cells	 were	 maintained	 in	 the	same	 media	 as	 NMuMGs	 supplemented	 with	 10	 mg/ml	 neomycin.	 E1KD-shCdc27	 cells	were	 generated	 in	 the	 laboratory	 by	 transducing	 E1KD	 cells	 with	 pLKO.1	 lentiviral	particles	 containing	 shRNA	 targeting	 Cdc27	 and	 a	 neomycin	 selection	 marker.	 E1KD-shCdc27	 cells	 were	 maintained	 in	 the	 same	 media	 as	 NMuMGs	 supplemented	 with	 10	
µg/ml	puromycin	and	10	mg/ml	neomycin.	The	Pak1	inhibitor	IPA-3	was	purchased	from	Selleck	Chemicals	(Houston,	TX,	USA)	used	at	a	concentration	of	30	µM	for	times	indicated	in	figures	unless	otherwise	noted	in	figures.	The	proteasome	inhibitor	MG132	was	obtained	from	Sigma-Aldrich	(St.	Louis,	MO,	USA)	and	was	used	at	a	concentration	of	10	µM	for	times	indicated	in	figures.		
Plasmids	pGEX-6P-Cdh1wt	(570)	was	a	gift	from	Jonathon	Pines	(Addgene	plasmid	#	 39877).	 pECE-M2-CDC27	 was	 a	 gift	 from	 Anne	 Brunet	 (Addgene	 plasmid	 #	 31661).	pLKO.1	neo	was	a	gift	 from	Sheila	 Stewart	 (Addgene	plasmid	#	13425).	pGEX-6P-hnRNP	E1wt	was	a	generous	gift	from	Rakesh	Kumar.		
Cell	 synchronization	 Cell	 synchronization	 was	 performed	 to	 analyze	 cell	 cycle-specific	 expression	 of	 mRNAs	 and	 proteins.	 Cells	 were	 synchronized	 in	 G0	 phase	 by	incubating	 in	 DMEM	 supplemented	 with	 0.5%	 fetal	 bovine	 serum	 for	 16	 hours.	Synchronization	at	G0,	while	convenient,	is	not	highly	effective	at	synchronizing	the	entire	population	of	 cells	on	a	 tissue	culture	plate.	Because	of	 this,	double-thymidine	block	was	used	to	effectively	synchronize	populations	of	cells	at	G1/S.	Briefly,	2	mM	thymidine	was	added	 to	 culture	media	 and	 cells	were	 incubated	 for	 16	 hours.	 The	media	was	 removed	after	16	hours	and	plates	were	washed	with	sterile	1X	PBS	three	times,	then	released	for	9	
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hours	by	addition	of	complete	medium.	Cells	were	then	blocked	again	by	addition	of	2	mM	thymidine.	Cells	were	synchronized	in	mitosis	by	first	blocking	with	2	mM	thymidine	for	16	hours,	 then	 washing	 three	 times	 in	 1X	 sterile	 PBS	 and	 releasing	 directly	 into	 complete	medium	 supplemented	 with	 50	 ng/mL	 nocodazole	 for	 12	 hours.	 Mitotic	 cells	 were	harvested	after	12	hours	of	incubation	with	nocodazole,	or	washed	three	times	in	1X	sterile	PBS	and	 released	 into	 complete	medium	 to	 allow	 cells	 to	 complete	mitosis	 and	progress	into	early	G1	phase.	G1	cells	were	harvested	4	hours	after	release	from	nocodazole	block.		
DAVID	 analysis	 of	 hnRNP	 E1-regulated	 genes	 Affymetrix	 array	 analysis	 was	performed	previously	(Hussey	et	al.,	2012)	to	generate	a	dataset	containing	genes	that	are	post-transcriptionally	 regulated	 by	 hnRNP	 E1.	 Enrichment	 of	 biological	 processes	 and	pathways	 in	 the	 geneset	 was	 assessed	 using	 the	 DAVID	 webtool	 (Huang,	 Sherman,	 &	Lempicki,	2008,	2009).	The	cutoff	for	gene	expression	change	between	NMuMG	monosome	and	E1KD	polysome	samples	was	1.5	fold.		
Whole	 cell	 lysate	 preparation	Whole	 cell	 lysates	 were	 prepared	 by	 aspirating	culture	 medium,	 then	 washing	 cultured	 cells	 three	 times	 with	 ice	 cold	 1X	 phosphate-buffered	 saline	 (PBS).	 RIPA	 lysis	 buffer	 with	 protease	 and	 phosphatase	 inhibitors	 was	added	directly	to	cells.	Cells	were	scraped	and	transferred	to	microfuge	tubes,	incubated	on	ice	10	minutes,	sonicated,	then	centrifuged	at	high	speed.	Supernatants	were	transferred	to	new	tubes	and	protein	content	was	measured	by	Bradford	assay	using	known	dilutions	of	bovine	serum	albumin	to	generate	a	standard	curve.	Bradford	Protein	Assay	reagent	was	obtained	from	Bio-Rad	(Hercules,	CA,	USA)	and	absorbance	was	measured	at	595	nm	on	a	Perkin	Elmer	Wallac	1420	Victor2	microplate	reader	(Perkin	Elmer;	Waltham,	MA,	USA).		
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Immunoblot	 analysis	 To	 assess	 protein	 expression	 in	 cells,	 whole	 cell	 lysates	prepared	 as	 described	 above	 were	 denatured	 by	 addition	 of	 4X	 sample	 buffer	 (to	 1X	dilution)	and	boiling	for	5	minutes	at	95°C.	Lysates	were	then	resolved	by	denaturing	SDS-polyacrylamide	 gel	 electrophoresis	 (SDS-PAGE)	 and	 transferred	 to	 polyvinylidene	difluoride	(PVDF)	membrane.	Membranes	were	blocked	to	prevent	nonspecific	binding	of	antibody	in	5%	milk	in	1X	TBS-T	or	5%	bovine	serum	albumin	in	1X	TBS-T	for	30	minutes	at	 room	 temperature.	 Primary	 antibodies	were	 diluted	 1:1000	 in	 5%	milk/TBS-T	 or	 5%	BSA/TBS-T	 and	membranes	 incubated	 overnight	 at	 4°C	with	 gentle	 rocking.	Membranes	were	 washed	 three	 times	 for	 15	 minutes	 each	 in	 1X	 TBS-T,	 and	 then	 incubated	 in	secondary	antibody	(diluted	1:10,000	in	5%	milk/TBS-T)	for	1	hour	at	room	temperature.	Membranes	 were	 washed	 three	 times	 for	 15	 minutes	 each	 in	 1X	 TBS-T,	 then	 Luminata	Forte	 Western	 HRP	 substrate	 (EMD	 Millipore;	 Billerica,	 MA,	 USA)	 was	 added	 and	membranes	 were	 exposed	 using	 Bio-Rad	 ChemiDoc	 MP	 system	 (Bio-Rad;	 Hercules,	 CA,	USA).		
Reverse	 transcription	of	 total	RNA	To	assess	expression	of	mRNAs	in	cells,	total	RNA	was	isolated	from	cells	using	Trizol	reagent	(Life	Technologies/ThermoFisher;	Grand	Island,	 NY,	 USA)	 according	 to	 the	manufacturer’s	 protocol.	 Complementary	 DNA	 (cDNA)	was	transcribed	from	2	µg	total	RNA	using	M-MLV	reverse	transcriptase	(Sigma	Aldrich;	St.	Louis,	MO,	USA)	and	oligo	dT	primers	(Invitrogen/ThermoFisher;	Grand	Island,	NY,	USA).		
Semi-quantitative	 polymerase	 chain	 reaction	 (PCR)	 PCR	was	performed	using	Maxima	 Hot-Start	 Taq	 DNA	 polymerase	 (Life	 Technologies/ThermoFisher;	 Grand	 Island,	NY,	USA).	PCR	products	were	electrophoresed	on	2%	agarose	gels	 stained	with	ethidium	
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bromide	and	visualized	using	BioRad	ChemiDoc	system.	Primer	sequences	are	described	in	Table	1.		
Gene Primer Sequence 
Cdc27 forward 5’ – TGGGTCAAACTCATCTCGCC – 3’  
Cdc27 reverse 5’ – GGTGACGAATGACGGCAATG – 3’  
Actb forward 5’ – TCATGAAGTGTGACGTTGACATCCGT – 3’ 
Actb reverse 5’ – CCTAGAAGCATTTGCGGTGCACGATG – 3’  
L1CAM forward 5’ – GTCCCTCACGTTGGGAATGT – 3’  
L1CAM reverse 5’ – AGAGGGCTCATCAACAGACC – 3’  
Fzr1 forward 5’ – CGTGACCGCATGATCCTACA – 3’  
Fzr1 reverse 5’ – TGTGTGCTCACCAGCTCATT – 3’ 
pSilencer forward 5’ – CAGTGCTGCAATGATACCGC – 3’ 
pSilencer reverse 5’ – GGGAACCGGAGCTGAATGAA – 3’  
Table 1:  Gene-specific sequences of primers used for PCR. 	
S100	Fraction	Cell	Lysate	Preparation	S100	fractions	were	utilized	for	polysome	profile	 analysis.	 The	 S100	 fraction	 of	 a	 cell	 lysate	 specifically	 contains	 the	 cytoplasmic	contents	of	cells,	and	since	ribosomal	translation	occurs	in	the	cytosol.	S100	fractions	were	prepared	by	washing	cultured	cells	 three	 times	 in	 ice	 cold	1X	PBS.	S100	 lysis	buffer	was	added	directly	to	cells	and	they	were	scraped	and	transferred	to	microfuge	tubes.	Lysates	were	passed	through	26G	needles	ten	times	on	ice,	then	incubated	on	ice	10	minutes	and	finally	centrifuged	at	10,000	x	g	for	5	minutes.	Supernatants	were	transferred	to	new	tubes	and	kept	on	ice	for	immediate	use.		
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Polysome	profile	analysis	Polysome	profile	analysis	determines	the	level	at	which	a	transcript	is	being	translated	into	protein,	sedimenting	mRNA	based	on	its	density,	which	is	 proportional	 to	 the	 number	 of	 ribosomal	 subunits	 with	 which	 it	 is	 associated.	 Those	mRNAs	being	 translated	at	a	high	rate	will	 sediment	 to	heavier	 fractions,	as	 they	contain	many	complete	80S	ribosomes,	whereas	poorly	translating	mRNAs	will	sediment	to	lighter	fractions,	 as	 they	 contain	 fewer	 ribosomes.	 S100	 fractions	 were	 layered	 onto	 10-50%	sucrose	density	gradients	and	centrifuged	at	35,000	x	g	for	3	hours	at	4°C.	Fractions	were	then	removed	from	the	column	by	pushing	80%	sucrose	 from	the	bottom	of	 the	gradient	and	removing	fractions	from	the	top.	Absorbance	at	254	nanometers	was	recorded	for	each	fraction	as	it	was	collected.		
Immunoprecipitations	There	is	currently	no	primary	antibody	to	detect	phospho-hnRNP	 E1	 directly,	 so	 an	 indirect	 approach	 was	 utilized	 where	 hnRNP	 E1	 was	immunoprecipitated	 from	 whole	 cell	 lysates,	 then	 assayed	 by	 immunoblot	 for	phosphoserine	 or	 phosphothreonine.	 Immunoprecipitations	 were	 carried	 out	 by	incubating	1	mg	whole	cell	lysate	with	5	µg	Abnova	α-PCBP1	primary	antibody	in	a	volume	of	 500	µl	 overnight	 at	 4°C	with	 end-over-end	 rotation.	 Protein	 A-sepharose	 beads	were	washed	three	times	in	RIPA	lysis	buffer,	and	then	50	µl	beads	were	added	to	each	sample	and	 incubated	 at	 4°C	 with	 end-over-end	 rotation	 for	 a	 minimum	 of	 3	 hours.	 After	incubation,	 beads	 were	 washed	 a	 minimum	 of	 five	 times	 with	 RIPA	 lysis	 buffer,	 then	transferred	to	a	new	tube	before	removing	all	wash	buffer	from	the	beads	and	adding	50	µl	1X	 Laemmli	 sample	 buffer.	 Samples	were	 boiled	 for	 5	minutes	 before	 being	 loaded	 onto	SDS-PAGE	 gels,	 electrophoresed,	 and	 transferred	 to	 PVDF	 membrane	 for	 subsequent	immunoblot	analysis.		
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RNA-immunoprecipitation	To	assay	mRNA	binding	 to	hnRNP	E1	protein,	hnRNP	E1	 was	 immunoprecipitated	 from	 lysates	 followed	 by	 RNA	 isolation.	 RNA-immunoprecipitations	were	performed	as	described	above	with	some	minor	modifications.	Briefly,	 all	 buffers	 were	 prepared	 in	 diethyl	 pyrocarbonate-treated	 water	 and	 RNase	inhibitors	were	added	to	the	antibody-lysate	mixture	for	overnight	 incubation.	After	 final	washing	of	beads	and	transfer	 to	new	microfuge	tubes,	all	wash	buffer	was	removed	and	Trizol	reagent	was	added	to	isolate	RNA	bound	to	the	immunoprecipitated	hnRNP	E1.	Total	RNA	was	prepared	according	to	Trizol	manufacturer’s	instructions.	Total	RNA	was	reverse-transcribed	 into	 cDNA	 as	 described	 above,	 and	 semi-quantitative	 PCR	was	 performed	 as	described	above.		
Site-directed	 mutagenesis	 Site-directed	 mutagenesis	 was	 performed	 to	 mutate	pGEX-6P-hnRNP	 E1wt	 plasmid	 using	 Agilent	 QuikChange	 Site-Directed	 Mutagenesis	 Kit	(Agilent	 Technologies;	 Santa	 Clara,	 CA,	 USA)	 according	 to	 the	 manufacturer’s	 protocol.	Primers	were	designed	using	QuikChange	Primer	Design	Program	 (Agilent	Technologies;	Santa	Clara,	CA,	USA).	Single	mutations	were	carried	out	sequentially	and	DNA	sequencing	was	 performed	 by	 Genewiz	 (Genewiz;	 South	 Plainfield,	 NJ,	 USA)	 on	 plasmids	 to	 validate	mutation.	
In	vitro	kinase	assay	Pak1	kinase	was	immunopurified	from	synchronized	NMuMG	cell	 lysates	 prepared	 in	 kinase	 lysis	 buffer.	 To	 isolate	 the	 kinase,	 250	 µg	 of	 lysate	 was	incubated	with	2.5	µg	α-Pak1	antibody	(Abcam;	ab40852)	and	30	µl	Protein	A	Sepharose	(GE	Life	Sciences)	beads	in	a	total	volume	of	250	µl	 for	4	hours	at	4°C	with	end-over-end	rotation.	 Complexes	 were	 collected	 by	 centrifugation	 at	 2,000	 rpm	 for	 3	 minutes	 and	washed	five	times	in	ice-cold	kinase	lysis	buffer.	After	washing,	the	supernatant	was	totally	
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removed	 from	kinase/bead	 complexes	 and	 they	were	 immediately	 resuspended	 in	 30	µl	kinase	assay	buffer.	Kinase	reactions	were	initiated	by	adding	5	µg	substrate	protein	[GST-WT-hnRNP	E1,	GST-phosphomutant-hnRNP	E1,	or	recombinant	Histone	H4	(New	England	Biolabs)]	and	0.5	µCi	[γ32P]-ATP	(Perkin	Elmer;	3000	Ci/mmol)	in	20	µl	kinase	buffer.	The	reaction	was	allowed	to	proceed	at	30°C	for	20	minutes,	then	terminated	with	the	addition	of	1X	Laemlli	sample	buffer	and	heating	to	95°C	for	2	minutes.	Samples	were	resolved	by	SDS-PAGE	on	a	15%	reducing	polyacrylamide	gel	and	analyzed	by	autoradiography.		
In	vitro	ubiquitination	assay	APC/C	was	affinity	purified	from	synchronized	whole	cell	lysates	to	compare	E3	ligase	activity	at	different	phases	of	the	cell	cycle	in	different	cell	lines.	Protein	A-Sepharose	beads	(GE	Healthcare	Life	Sciences;	Marlborough,	MA,	USA)	and	
α-Cdc16	(sc365636	-	Santa	Cruz	Biotechnology;	Dallas,	TX,	USA)	antibody	were	conjugated	by	 overnight	 incubation	 with	 end-over-end	 rotation	 at	 4°C.	 Cells	 were	 synchronized	 as	described	 above,	 using	 thymidine-nocodazole	 block	 and	 release	 to	 isolate	mitotic-APC/C	and	 G1-APC/C,	 respectively.	 Plates	 were	 washed	 three	 times	 in	 1X	 ice-cold	 PBS,	 then	scraped	and	centrifuged	in	PBS	to	obtain	cell	pellets.	Pellets	were	lysed	in	3	pellet	volumes	of	ubiquitination	lysis	buffer.	Lysates	were	incubated	with	10	µl	antibody/beads	at	4°C	for	2	hours	in	a	volume	of	100	µl.	Affinity-purified	APC/C	was	washed	on	beads	three	times	in	1X	 TBS-T.	 To	 initiate	 ubiquitination	 reactions,	 immunoprecipitates	 were	 incubated	 with	200	nM	recombinant	substrate	(myc-Cyclin	B1	residues	1-102	or	full-length	GST-Cdh1),	1X	ubiquitination	 reaction	 buffer,	 250	 nM	 UBE1	 (ubiquitin	 activating	 enzyme)	 (Boston	Biochem;	Cambridge,	MA,	USA),	 1	µM	His-UbcH10	 (ubiquitin	 conjugating	 enzyme),	 1	µM	His-Ube2S	 (ubiquitin	 conjugating	 enzyme),	 1	 mg/ml	 creatine	 phosphokinase	 (Sigma-Aldrich;	St.	Louis,	MO,	USA),	to	a	volume	of	10	ul	with	water.	Reactions	were	incubated	at	
 25	
37°C	for	1	hour	with	shaking	at	1000	rotations	per	minute.	To	stop	reactions,	5	µl	Laemmli	sample	buffer	was	added	and	 reactions	were	vortexed.	Reactions	were	 loaded	onto	10%	SDS-polyacrylamide	 gels	 for	 electrophoresis	 and	 subsequent	 immunoblot	 analysis.	 Myc-Cyclin	B1,	His-UbcH10,	and	His-Ube2S	were	generous	gifts	of	Dr.	Aaron	Tipton	(Oklahoma	Medical	Research	Foundation;	Oklahoma	City,	OK,	USA).		
Flow	cytometry	To	evaluate	the	distribution	of	populations	of	cells	throughout	the	cell	cycle,	propidium	iodide	staining	of	DNA	and	subsequent	flow	cytometric	analysis	was	performed.	Cultured	cells	were	trypsinized	and	centrifuged	at	1000	rpm	for	3	minutes	to	pellet.	After	decanting	culture	media,	pellets	were	resuspended	in	300	µl	1X	PBS	and	700	µl	of	100%	ethanol	was	added	drop-wise	with	 low-speed	vortexing.	Cells	were	 incubated	at	4°C	overnight	 to	 fix	and	permeabilized	completely.	To	ensure	 that	only	cellular	DNA	was	stained,	 RNase	 A	 was	 added	 at	 a	 concentration	 of	 8	 µg/ml	 and	 the	 suspensions	 were	incubated	 at	 4°C	 for	 an	 hour	 to	 allow	 complete	 degradation	 of	 cellular	 RNA.	 Propidium	iodide	 was	 then	 added	 to	 samples	 at	 a	 concentration	 of	 50	 µg/ml	 and	 samples	 were	transferred	 to	 flow	 cytometry	 tubes	 after	 being	 strained	 through	 40	 µm	 cell	 strainers.	Samples	were	 incubated	 in	 the	 dark	 for	 at	 least	 30	minutes	 at	 25°C,	 and	 then	 analyzed	using	a	BD	FACSAria	(BD	Biosciences;	San	Jose,	CA,	USA)	flow	cytometer	and	FACSDiva	(BD	Biosciences;	San	Jose,	CA,	USA)	software.	Data	was	then	analyzed	using	FCS	Express	5	Plus	software	(De	Novo	Software;	Glendale,	CA,	USA).	Cells	were	gated	first	by	plotting	forward	scatter	height	 versus	 side	 scatter	height	 to	 separate	 cells	 from	cellular	debris.	The	gated	population	 was	 then	 gated	 again	 by	 plotting	 propidium	 iodide	 width	 versus	 propidium	iodide	area.	This	allowed	for	the	gating	of	single	cells.	Histograms	were	then	prepared	from	the	gated	single	cell	populations	and	distribution	of	cells	in	cell	cycle	phases	was	analyzed	
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using	the	MultiCycle	AV	DNA	Analysis	Plug-in	of	FCS	Express	5	Plus	software,	specifically	utilizing	the	Dean-Jett	mathematical	model	of	DNA	distribution	(Dean	&	Jett,	1974).		
Immunocytochemistry	 Immunocytochemistry	was	performed	using	fluorescence-labeled	 primary	 antibodies	 and	 DAPI.	 Cells	 were	 cultured	 on	 glass	 coverslips	 in	 6	 well	tissue	 culture	 plates.	 To	 prepare	 coverslips	 for	mounting	 onto	 slides,	 culture	media	was	aspirated	and	cells	were	fixed	by	incubating	in	4%	paraformaldehyde	prepared	in	1X	PBS	for	20	minutes	at	25°C	with	gentle	rocking.	Cells	were	washed	three	times	for	10	minutes	each	in	1X	PBS,	then	permeabilized	and	blocked	simultaneously	by	incubating	2%	BSA	and	0.2%	Triton	 X-100	 prepared	 in	 1X	 PBS	 (blocking	 buffer)	 for	 1	 hour	 at	 25°C	with	 gentle	rocking.	 Alexa	 fluor	 488-conjugated	 α-alpha	 Tubulin	 antibody	 was	 diluted	 1:1000	 in	blocking	 buffer	 and	 added	 to	wells	 to	 cover	 coverslips,	 then	 incubated	 in	 the	 dark	 for	 1	hour	 at	 25°C	with	 gentle	 rocking.	 Cells	were	washed	 again	 three	 times	 in	1X	PBS	 for	10	minutes	 each.	A	 single	drop	of	mounting	medium	with	DAPI	was	 added	 to	 a	microscope	slide,	and	then	coverslips	were	carefully	removed	from	wells	of	plate	using	fine	forceps	and	placed	on	slides,	cells	down.	Coverslips	were	sealed	using	clear	nail	polish	and	allowed	to	dry	 in	 the	 dark	 before	 imaging	 slides	 using	 an	 Olympus	 FV10i	 laser	 scanning	 confocal	microscope.		
Metaphase	spread	analysis	To	determine	the	percentage	of	aneuploid	metaphase	chromosomes	 in	 a	 cell	 line,	 metaphase	 chromosome	 spreads	 were	 prepared.	 Cells	 were	cultured	 in	 colcemid	 (KaryoMAX/ThermoFisher;	 Grand	 Island,	 NY,	 USA)	 at	 a	 final	concentration	of	1	µg/ml	at	37°C	for	1	hour.	Culture	media	was	aspirated	and	cells	washed	in	 1X	 PBS,	 then	 trypsinized	 and	 centrifuged	 at	 1000	 rpm	 for	 4	 minutes	 to	 pellet.	 The	supernatant	 was	 decanted	 and	 the	 pellet	 was	 resuspended	 in	 the	 remaining	 media	
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(approximately	 200	µl)	 by	 gentle	 trituration.	 5	ml	 of	 ice-cold	 0.56%	 potassium	 chloride	was	 added	 to	 swell	 the	 cells	 and	 incubated	 at	 25°C	 for	 6	 minutes,	 then	 cells	 were	centrifuged	at	1000	rpm	for	4	minutes	to	pellet	again.	After	decanting	supernatant,	pellets	were	 resuspended	 in	 the	 remaining	 volume	 of	 potassium	 chloride	 solution	 by	 gentle	trituration.	Ice-cold	fixative	(3:1	methanol:	glacial	acetic	acid)	was	added	drop-wise	to	cells	while	vortexing	on	low	speed.	The	suspension	was	centrifuged	at	1000	rpm	for	4	minutes	to	pellet	 fixed	cells.	The	 fixative	was	decanted	and	cell	pellets	were	 resuspended	 in	1	ml	fixative.	A	small	volume	(20	µl)	of	fixed	cell	suspension	was	released	in	single	drops	from	a	height	 of	 approximately	50	 cm	onto	 clean,	 dry	microscope	 slides	over	 a	beaker	of	warm	water.	At	 least	2	slides	were	prepared	per	cell	 line.	Slides	were	allowed	to	dry	overnight,	and	 then	 mounting	 medium	 with	 DAPI	 was	 added	 to	 slides	 and	 coverslips	 placed	 and	sealed	 with	 clear	 nail	 polish.	 Metaphases	 were	 imaged	 using	 an	 Olympus	 FV10i	 laser	scanning	confocal	microscope	and	counted	using	 ImageJ	software	(National	 Institutes	 for	Health;	 Bethesda,	 MD,	 USA)	 with	 the	 cell	 count	 plugin.	 At	 least	 50	 metaphases	 were	counted	per	cell	line.		
Generation	of	 in	vivo	 selected	M1P,	 L1P,	 and	L2P	 cell	 lines	Nonobese	diabetic	severe	combined	immunodeficient	(NOD/SCID)	mice	were	supplied	by	the	National	Cancer	Institute	 (NCI;	 Bethesda,	MD,	USA).	 The	 Institutional	 Animal	 Care	 and	Use	 Committee	 at	Medical	 University	 of	 South	 Carolina	 approved	 all	 mouse	 procedures	 performed.	 To	generate	cells	that	were	increasingly	aggressive	in	breast-to-lung	metastasis,	50,000	E1KD	cells	 suspended	 in	 100	µl	 sterile	 1X	 PBS	were	 injected	 subcutaneously	 into	 the	 inguinal	mammary	 gland	 fat	 pads	 of	 6	 week-old	 NOD/SCID	 females	 using	 1	 CC	 syringe	 and	 26G	hypodermic	 needle.	 After	 15	 weeks,	 mice	 were	 euthanized	 using	 CO2	 inhalation	 and	
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cervical	dislocation.	Primary	tumors	and	lungs	were	excised	in	sterile	conditions,	and	then	tissue	 was	 enzymatically	 dissociated	 as	 follows:	 	 tumors	 or	 lungs	 were	 incubated	 with	DMEM	 and	 300	 U/ml	 collagenase	 and	 100	 U/ml	 hyaluronidase	 (StemCell	 Technologies;	Vancouver,	British	Columbia,	Canada)	at	37°C	for	4	hours	with	gentle	agitation	at	100	rpm.	Following	enzymatic	dissociation,	 cells	 centrifuged	at	350	x	g	 for	5	minutes,	 supernatant	decanted,	then	resuspended	in	a	1:4	mixture	of	cold	Hank’s	Balanced	Salt	Solution	(HBSS)	(StemCell	 Technologies)	 supplemented	 with	 2%	 FBS	 and	 ammonium	 chloride	 (StemCell	Technologies).	Cells	were	centrifuged	at	350	x	g,	supernatant	decanted,	then	resuspended	in	5	ml	pre-warmed	Trypsin-EDTA,	then	gently	triturated	for	1	minute	to	lyse	dead	cells.	10	ml	 of	 HBSS/2%	 FBS	 were	 added,	 then	 cells	 were	 centrifuged	 for	 5	minutes	 at	 350	 x	 g.	Supernatant	 was	 decanted	 and	 2	 ml	 of	 pre-warmed	 5	 mg/ml	 Dispase	 (StemCell	Technologies)	 and	 200	 µl	 1mg/ml	 DNase	 I	 (StemCell	 Technologies)	 were	 added	 to	 cell	pellets	and	gently	triturated	for	1	minute	to	digest	cellular	DNA	released	by	dead	cells.	10	ml	HBSS/2%	FBS	were	added	to	suspensions,	and	they	were	centrifuged	again	at	350	x	g	for	 5	minutes.	Resulting	 cell	 pellets	were	 resuspended	 in	 complete	DMEM	plus	1	mg/ml	puromycin,	 and	 then	 passed	 through	 40	 µm	 cell	 strainers	 to	 generate	 single	 cell	suspensions.	Cells	were	plated	on	10	cm	culture	dishes	and	maintained	 in	DMEM	with	1	mg/ml	puromycin.	To	generate	more	aggressive	E1KD	cells,	50,000	L1P	cells	were	injected	into	 the	 inguinal	 mammary	 fat	 pads	 of	 NOD/SCID	 females	 as	 described	 previously,	 and	resulting	lung	metastases	were	isolated	as	described	above	after	5	weeks	due	to	significant	morbidity.		
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In	vitro	migration	Migration	was	assessed	using	 the	CytoSelect™	24-Well	Wound	Healing	Assay	(Cell	Biolabs).	Briefly,	wound-healing	inserts	were	removed	from	confluent	monolayers	and	cells	were	fixed	and	stained	24	hours	after	removal	of	inserts.		
3D	 in	vitro	invasion	 Invasion	of	E1KD	progression	series	cells	was	assessed	using	the	Trevigen	spheroid	invasion	assay	as	per	manufacturer’s	instructions.	Briefly,	a	volume	of	 50ml	 single	 cell	 suspension	 in	 spheroid	 formation	 ECM	was	 prepared	 at	 a	 density	 of	3000	cells	per	well	of	a	round-bottomed	low-attachment	96	well	plate.	Once	seeded,	plates	were	centrifuged	at	200	g	for	3	min,	followed	by	incubation	at	37°C/	5%	CO2	for	48	hours.	A	volume	of	50ml	 invasion	matrix	was	added	per	well	of	plates	placed	on	ice	for	15	min	to	cool.	Following	addition	of	matrix,	plates	were	centrifuged	at	300	g	for	3	min	and	incubated	for	 1h	 at	 37°C	 to	 allow	 matrix	 to	 solidify	 prior	 to	 addition	 of	 100ml	 chemoattractant	(DMEM	 supplemented	 with	 10%FBS	 and	 20ng/ml	 EGF).	 Invasive	 protrusions	 from	spheroids	were	imaged	between	5	and	7	days	of	matrix	addition.	
In	vivo	lung	colonization	assay	100,000	E1KD,	L1P,	or	L2P	cells	were	injected	via	tail	vein	into	6	week-old	NOD/SCID	female	mice.	Cells	were	suspended	in	100	µl	sterile	1X	PBS	 and	 injections	 were	 performed	 using	 a	 28G	 sterile	 hypodermic	 needle	 and	 1	 CC	syringe.	Mice	were	euthanized	after	6	weeks	using	CO2	inhalation	and	cervical	dislocation.	Lungs	were	formalin-fixed	and	paraffin	embedded	for	immunohistochemical	analysis.	
Immunohistochemistry	 Formalin-fixed	 paraffin-embedded	 lungs	 from	mice	 that	had	 undergone	 tail	 vein	 injections	 of	 E1KD,	 L1P,	 and	 L2P	 cells	 were	 processed	 by	 the	Medical	 University	 of	 South	 Carolina	 Center	 for	 Oral	 Health	 Research	 (MUSC	 COHR).	Briefly,	5	µm	sections	were	cut	using	a	microtome,	deparaffinized,	and	then	stained	using	hematoxylin	and	eosin.	Histopathological	analysis	was	performed	by	the	MUSC	COHR.		
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Tissue	 Microarray	 and	 Immunohistochemistry	 Tissue	 microarray	 (TMA)	compilation	 and	 immunohistochemical	 staining	 was	 performed	 by	 the	 Hollings	 Cancer	Center	Biorepository	and	Tissue	Analysis	core.	The	TMAs	contained	matched	normal	and	tumor	tissue	samples,	as	well	as	normal	and	metastatic	lymph	node	tissue	from	patients	for	whom	 survival	 data	was	made	 available	 (Table	 3).	 For	 immunohistochemical	 staining	 of	formalin-fixed,	 paraffin-embedded	 TMAs	 and	 mouse	 lung	 tissue,	 sections	 were	deparaffinized	in	xylene,	rehydrated	in	ethanol	and	processed	as	follows:	the	sections	were	incubated	with	 target	retrieval	solution	(S2367;	Dako,	Carpinteria,	CA,	USA)	 in	a	steamer	for	 45 min	 followed	 by	 3%	 hydrogen	 peroxide	 solution	 for	 10 min	 and	 protein	 block	(X0909;	 Dako)	 for	 20 min	 at	 room	 temperature.	 Sections	were	 incubated	 overnight	 in	 a	humid	chamber	at	4oC	with	α-Cdc27	(Abcam;	dilution	of	1:1000,	pH	9.0)	or	α-Fzr1	(Abcam;	dilution	 of	 1:2000,	 pH	 6.0)	 antibodies	 followed	 by	 biotinylated	 secondary	 antibody	(PK6106;	Vector	laboratories,	Burlingame,	CA,	USA)	for	30 min	and	ABC	reagent	for	30 min.	Immunocomplexes	 of	 horseradish	 peroxidase	 were	 visualized	 by	 DAB	 reaction	 (K3468;	Dako),	and	sections	were	counterstained	with	hematoxylin	before	mounting.	Micrographs	of	 stained	 sections	were	 taken	 using	 an	 Olympus	 DP72	 8-bit	 RGB	 camera	with	 Cellsens	acquisition	software.	Images	were	stitched	together	using	Microsoft	ICE.		
Statistical	 analysis	 of	 tissue	 microarray	 results	 Staining	 of	 tissue	 microarray	samples	was	scored	on	a	scale	of	0	to	3	by	three	separate	individuals.	Scores	were	averaged	and	 statistical	 analysis	 was	 performed	 by	 two-tailed	 Student’s	 t-test	 of	 pair-wise	comparisons	or	one-way	ANOVA	followed	by	Tukey’s	post	hoc	 test.	Kaplan-Meier	survival	curves	 were	 analyzed	 using	 MedCalc	 Statistical	 Software	 (MedCalc	 Software;	 Ostend,	
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Belgium)	 with	 significance	 determined	 by	 the	 Logrank	 test.	 P<0.05	 were	 considered	statistically	significant.		
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IV.		Chapter	4:		Results		 HnRNP	 E1	 regulates	 translation	 of	 mRNAs	 involved	 in	 several	 cellular	
processes.	Previously,	we	showed	that	hnRNP	E1	represses	translation	of	specific	mRNAs	involved	 in	 epithelial-to-mesenchymal	 transition	 (EMT)	 by	 binding	 to	 their	 3’	 UTRs	 in	 a	TGFβ-sensitive	 manner	 (Chaudhury,	 Hussey,	 et	 al.,	 2010;	 Hussey	 et	 al.,	 2011).	 We	established	 a	 TGFβ-induced	 hnRNP	 E1-dependent	 EMT	 gene	 signature	 by	 combining	polysome	 profiling	with	 Affymetrix	 array	 analysis	 in	 normal	mouse	mammary	 epithelial	(NMuMG)	cells	and	NMuMGs	in	which	hnRNP	E1	had	been	stably	silenced	(E1KD)	(Hussey	et	 al.,	 2012).	 To	 better	 understand	 the	 role	 of	 hnRNP	 E1	 outside	 of	 TGFβ-mediated	translational	 regulation	 and	 EMT,	 the	 array	 data	 collected	was	 filtered	 to	 identify	 those	mRNAs	whose	expression	was	1.5-fold	higher	in	the	monosome	fractions	of	NMuMGs	and	1.5-fold	higher	in	the	polysome	fractions	of	E1KDs,	independent	of	TGFβ.	The	mRNAs	were	then	 subject	 to	 pathway	 analysis	 using	 DAVID	 functional	 annotation	 software.	 Many	biological	 pathways	 were	 significantly	 enriched	 in	 this	 dataset,	 including	 cell	 cycle	 (Fig.	1A).	Of	 the	genes	 identified	as	both	hnRNP	E1-dependent	and	 involved	 in	 cell	 cycle	 (Fig.	1B),	 Cdc27	 was	 of	 particular	 interest	 because	 of	 its	 role	 as	 a	 core	 component	 of	 the	anaphase	promoting	complex/cyclosome,	an	E3	ubiquitin	ligase	that	plays	an	integral	role	in	maintaining	chromosomal	integrity.		In	order	to	validate	the	results	of	the	array,	total	RNA	and	protein	expression	levels	were	 assessed	 in	 NMuMG	 and	 E1KD	 cells.	 While	 levels	 of	 Cdc27	 transcript	 remained	unchanged	between	cell	lines,	the	level	of	Cdc27	protein	was	higher	in	E1KD	cells	(Fig.	2A,	upper).	Polysome	profile	analysis	was	performed	 to	validate	 translational	 regulation	and	
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Cdc27	 mRNA	 primarily	 sedimented	 to	 the	 light	 monosomal	 fractions	 in	 NMuMGs	 in	contrast	to	its	sedimentation	to	the	dense	polysomal	fractions	in	E1KDs	(Fig.	2B,	lower).		
HnRNP	E1	regulates	Cdc27	expression	at	the	translational	level	in	a	cell	cycle-
dependent	manner.	Since	Cdc27	is	involved	in	cell	cycle	regulation,	we	hypothesized	that	its	expression	might	fluctuate	with	regard	to	cell	cycle	phase.	To	assess	this,	NMuMG	and	E1KD	 cells	were	 synchronized	 at	G0	by	 culturing	 in	DMEM	with	0.5%	FBS	 for	 16	hours.	Cells	were	then	stimulated	using	10%	fetal	bovine	serum	and	whole	cell	 lysates	and	total	RNA	were	collected	at	the	indicated	time	points.	In	the	NMuMG	cells,	Cdc27	expression	is	
A
B
DNA replication
DNA metabolism
Cell cycle
mRNA transcription
Nucleoside, nucleotide,
nucleic acid metabolism
0 0.02 0.04 0.06 0.08
P value
Pds5a
Rbms1
Psmd1
Cdc27
Foxp1
Dscc1
Esco1
Prim1
Trp53bp1
NMuMG NMuMGE1KD E1KD
Monosome Polysome Total RNAMonosome Polysome Total RNA
Figure 1
Figure 1: HnRNP E1 regulates translation of mRNAs in many
biological processes. (A) DAVID functional annotation analysis
of translationally-regulated genes identified in Affymetrix array of
monosomal NMuMG genes and polysomal E1KD genes (Student’s
t-test, fold change > 1.5 between groups and < 1.5 within groups).
Genes were annotated using Panther biological processes.
(B) Heat map showing differential signal strength intensities for cell
cycle genes between NMuMG and E1KD monosomes and polysomes
compared to total, unfractionated mRNA.
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increased	at	the	protein	level	during	progression	through	the	cell	cycle	(Fig.	3A)	while	no	change	 is	 observed	 in	 total	 mRNA	 (Fig.	 3B).	 Progression	 through	 the	 cell	 cycle	 was	validated	by	propidium	 iodide	 staining	of	 total	 cellular	DNA	 followed	by	 flow	cytometric	analysis	(Fig.	4).	In	the	E1KD	cells,	Cdc27	expression	is	constitutively	high	throughout	the	
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Figure 2: Cdc27 expression is upregulated translationally in
E1KD cells compared to NMuMG cells. (A) Left Semi-quantitative
RT-PCR using gene specific primers to Cdc27 and Actb (control)
on total RNA isolated from asynchronous populations of NMuMG
and E1KD cells. Right Immunoblot analysis examining protein
expression levels of Cdc27, hnRNP E1, and GAPDH (control) in
whole cell lysates isolated from asynchronous NMuMG and E1KD
cells. (B) Upper Semi-quantitative RT-PCR using gene specific primers
to Cdc27 and Actb (control) on polysome profiles of asynchronous
NMuMG and E1KD cells. Lower Traces of A254 profiles resulting from
NMuMG and E1KD polysome profiling.
 35	
cell	 cycle	 (Fig.	 3A)	with	 no	 observable	 change	 in	 total	mRNA	 transcript	 levels	 (Fig.	 3B).	Polysome	 profile	 analysis	 was	 repeated	 to	 validate	 the	 microarray	 findings.	 Cytosolic	extracts	from	synchronized	NMuMGs	and	E1KDs	were	subject	to	polysome	profile	analysis:		
Cdc27	 mRNA	 sediments	 to	 monosomal	 fractions	 in	 G0-synchronized	 NMuMGs	 and	 to	polysomal	 fractions	 after	 24	 hour	 restimulation	 with	 complete	 medium;	 Cdc27	mRNA	sediments	to	the	polysomal	fractions	irrespective	of	cell	cycle	phase	in	E1KDs	(Fig.	5A).		To	determine	whether	Cdc27	mRNA	and	hnRNP	E1	interact	directly	within	the	cell,	RNA-immunoprecipitation	 was	 performed.	 Immunoprecipitation	 of	 hnRNP	 E1	 from	synchronized	 cytosolic	 cell	 extracts	 followed	by	RNA	 isolation	 and	 semi-quantitative	RT-PCR	 reveals	 that	Cdc27	mRNA	 binds	 hnRNP	 E1,	 and	 this	 binding	 is	 lost	 upon	mitogenic	stimulation	(Fig.	5B).	L1CAM	mRNA	binding	to	hnRNP	E1	has	been	included	as	a	positive	
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Figure 3: Cdc27 expression is regulated at the protein level and
not the mRNA level during the cell cycle. (A) Immunoblot analysis
of protein expression of Cdc27 and Hsp90 (control) in NMuMG and
E1KD cells that were synchronized by overnight culturing in DMEM +
0.5% FBS then released by addition of complete medium. (B) Semi-
quantitative RT-PCR using gene specific primers for Cdc27 and Actb
(control) on total RNA isolated from NMuMG and E1KD cells that were
synchronized as in (A) above.
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control,	as	it	has	been	shown	by	others	that	hnRNP	E1	protein	and	L1CAM	mRNA	interact	in	a	cell	cycle-dependent	manner.	Actb	mRNA	is	included	as	a	negative	control,	as	well	as	immunoprecipitation	carried	out	using	IgG	instead	of	antibody.	Input	samples	are	included	to	show	equal	loading	of	protein	in	immunoprecipitation	reactions.	
Pak1	phosphorylates	HnRNP	E1	in	a	cell	cycle-dependent	manner,	allowing	for	
Cdc27	 translation.	 Because	 Cdc27	 expression	 did	 not	 increase	 with	 TGFβ	 stimulation,	other	 potential	 kinases	 were	 considered	 for	 cell	 cycle-dependent	 hnRNP	 E1	phosphorylation.	 It	 has	 been	 shown	 previously	 by	 others	 that	 p21-activated	 kinase	 1	(Pak1)	phosphorylates	hnRNP	E1	in	response	to	mitogenic	stimulation	(Meng	et	al.,	2007).	To	 assess	 whether	 Pak1	 might	 phosphorylate	 hnRNP	 E1	 during	 the	 cell	 cycle,	immunoprecipitation	was	performed	on	NMuMG	cell	extracts	that	had	been	synchronized	by	double	thymidine	block,	then	released	with	or	without	the	Pak1-specific	inhibitor,	IPA-3.	
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Figure 4: Progression of G0-synchronized NMuMG and E1KD cells
through the cell cycle. Histograms representing propidium iodide staining
in G0-synchronized populations of NMuMG and E1KD cells. Cells were
synchronized by culturing in DMEM + 0.5% FBS overnight, then releasing
into complete medium. Cells were gated from debris, then gated again on
singlets to obtain analyses of populations of single cells.
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α-hnRNP	E1	antibody	or	IgG	were	used	with	Protein	A	Sepharose	beads	to	immunopurify	hnRNP	 E1	 from	 the	 cell	 extracts,	 then	 immunopurified	 hnRNP	 E1	was	 resolved	 by	 SDS-PAGE.	 Immunoblot	 analysis	was	 performed	 using	 antibody	 that	 recognizes	 substrates	 of	arginine-directed	kinases.	The	motif	recognized	is	RXXS*/T*,	where	the	serine	or	threonine	with	 the	 asterisk	 is	 phosphorylated.	 The	 two	 Pak1	 phosphorylation	 sites	 on	 hnRNP	 E1	identified	by	Meng	et	al.	(threonine	60	and	threonine	127)	both	have	an	arginine	at	the	-3	position.	An	increase	in	phosphorylated	hnRNP	E1	can	be	observed	following	release	from	
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Figure 5: Cdc27 expression is regulated translationally during
the cell cycle and interacts directly with hnRNP E1 in a cell
cycle-dependent manner. (A) Semi-quantitative RT-PCR analysis
using gene specific primers for Cdc27 using RNA isolated from NMuMG
and E1KD polysome profiling of G0-synchronized and cells released
for 18 hours. (B) Semi-quantitative RT-PCR using gene specific primers
for Cdc27, L1CAM, and Actb (control) using RNA isolated from anti-
hnRNP E1 immunoprecipitates. HnRNP E1 was immunopurified from
NMuMG cell extracts synchronized at G1/S by double-thymidine block,
then released for times indicated in the figure.
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thymidine	block,	and	this	increase	in	phosphorylation	is	inhibited	by	the	presence	of	IPA-3	(Fig.	6A).	The	membrane	was	then	stripped	and	re-probed	using	α-hnRNP	E1	antibody	to	show	equal	loading.		Pak1,	 like	 many	 kinases,	 is	 activated	 by	 phosphorylation	 (Maroto,	 Ye,	 von	Lohneysen,	Schnelzer,	&	Knaus,	2008).	To	assess	the	temporal	activation	of	Pak1	in	relation	to	hnRNP	E1	phosphorylation	and	Cdc27	expression,	NMuMG	cells	were	synchronized	at	the	G1/S	transition	using	double	thymidine	block,	then	released	in	the	presence	or	absence	
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Figure 6: HnRNP E1 is phosphorylated in vivo during the
cell cycle coinciding with Cdc27 expression. (A) Immunoblot
analysis of phosphorylated-RXXS*/T* from anti-hnRNP E1 or
IgG (control) immunoprecipitates isolated from NMuMG cells
synchronized at G1/S using double-thymidine block, then
released -/+ the Pak1-specific inhibitor, IPA-3 for times indicated
in the figure. Membrane was stripped and re-probed using
anti-hnRNP E1 antibody. (B) Immunoblot analysis of protein
expression using anti-Cdc27, anti-phospho-Pak1, and anti-GAPDH
(control) whole cell lysates isolated from NMuMG and E1KD cells
synchronized and released -/+ IPA-3 as described above.
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of	 Pak1	 inhibitor,	 IPA-3.	 Immunoblot	 analysis	 of	 cell	 extracts	 with	 α-phospho-Pak1	antibody	was	performed,	and	phosphorylation	of	Pak1	kinase	can	be	observed	shortly	after	release	from	G1/S	arrest	(Fig.	6B),	and	this	phosphorylation	is	inhibited	in	the	presence	of	IPA-3.	 This	 phosphorylation	 event	 precedes	 the	 observed	 increase	 in	 Cdc27	 expression	(Fig.	 6B).	 Furthermore,	 inhibition	 of	 Pak1	 activation	by	 the	Pak1-specific	 inhibitor	 IPA-3	results	in	decreased	Cdc27	expression	in	NMuMGs,	but	not	in	the	E1KDs	(Fig.	6B).	GAPDH	was	used	as	a	loading	control	for	the	experiment	(Fig.	6B).		To	determine	whether	 the	Pak1	 inhibitor,	 IPA-3,	had	any	effect	on	hnRNP	E1	and	
Cdc27	mRNA	 interaction,	 RNA-immunoprecipitation	 was	 performed	 in	 the	 presence	 of	increasing	 concentrations	 of	 IPA-3.	 NMuMG	 cells	 were	 arrested	 using	 double	 thymidine	block,	then	released	in	the	presence	or	absence	of	30	µM,	40	µM,	or	50	µM	IPA-3.	Cells	were	lysed	 and	 immunoprecipitation	 was	 performed	 using	 cell	 extracts	 and	 α-hnRNP	 E1	antibody	or	IgG.	Release	of	Cdc27	mRNA	from	hnRNP	E1	was	observed	at	3	hours	and	was	inhibited	in	the	presence	of	Pak1	inhibitor	(Fig.	7).		
0 1 3 3 3 3 0 1 3 3 3 3 0 1 3 3 3 3 hours after Thy release
IP: hnRNP E1Input IP: IgG
0 0 0 30 40 50 0 0 0 30 40 50 0 0 0 30 40 50 uM IPA-3
RT-PCR: Cdc27
RT-PCR: Actb
Figure 7
Figure 7: Cdc27 mRNA interacts with hnRNP E1 directly, and this
interaction is stabilized by the addition of IPA-3. Semi-quantitative
RT-PCR using gene specific primers for Cdc27 and Actb (control) from
RNA isolated from hnRNP E1 immunoprecipitates. HnRNP E1 was
immunopurified from NMuMG cells synchronized at G1/S using double-
thymidine block, the release -/+ increasing concentrations of IPA-3,
indicated in the figure.
 40	
Finally,	we	show	that	endogenous	Pak1	can	phosphorylate	recombinant	GST-hnRNP	E1	 in	 vitro.	GST-tagged	 wild-type	 hnRNP	 E1	 was	 used,	 as	 well	 as	 GST-tagged	 phospho-mutant	hnRNP	E1	in	which	threonine	60	and	threonine	127	were	both	mutated	to	alanine.	Recombinant	histone	H4	was	used	as	a	positive	control,	as	it	is	a	known	substrate	of	Pak1	(Maroto	 et	 al.,	 2008).	 Whole	 cell	 extracts	 were	 isolated	 from	 NMuMGs	 that	 had	 been	synchronized	 at	 G1/S	 by	 double-thymidine	 block	 and	 then	 released	 into	 S	 phase	 by	removal	of	thymidine	and	mitogen	stimulation.	Pak1	was	affinity-purified	from	the	whole	cell	 extracts	using	α-Pak1	antibody	and	Protein	A	Sepharose	beads.	The	 immunopurified	kinase	 was	 then	 incubated	 with	 GST-WT-hnRNP	 E1,	 GST-T60A,	 T127A-hnRNP	 E1,	 or	recombinant	 histone	 H4	 in	 the	 presence	 of	 [ϒ32P]-ATP.	 In	 vitro	 phosphorylation	 of	 both	GST-WT-hnRNP	E1	and	recombinant	histone	H4	by	 immunopurified	Pak1	 increases	after	mitogen	 stimulation	 (Fig.	 8).	 The	 phospho-mutant	 GST-T60A,	 T127A-hnRNP	 E1	 is	 not	phosphorylated	in	vitro	by	immunopurified	Pak1	(Fig.	8).	
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Figure 8: Pak1 phosphorylates recombinant hnRNP E1 in vitro.
Autoradiography images from in vitro kinase reactions. Pak1 was
immunopurified from NMuMG cells synchronized at G1/S using double-
thymidine block, then released for times indicated in the image.
Incorporation of y-[32P]-ATP into GST-hnRNP E1-WT, GST-hnRNP E1-
phosphomutant (T60A T127A), and Histone H4 (control) are visualized.
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The	APC/CCdh1	is	impaired	in	E1KD	cells	as	Cdh1	is	constitutively	degraded	by	
the	26S	proteasome.		In	order	to	determine	whether	constitutive	expression	of	Cdc27	was	affecting	 its	 normal	 function	 in	 the	 cell,	 we	 first	 assessed	 the	 expression	 level	 of	 APC/C	substrates.	Whole	cell	 lysates	were	prepared	from	NMuMG	and	E1KD	cells	 that	had	been	synchronized	 at	 G0	 as	 described	 previously.	 Lysates	 were	 resolved	 by	 SDS-PAGE	 and	immunoblot	analysis	was	performed.	Plk1,	a	substrate	of	the	APC/C	bound	to	its	cofactor	Cdh1	 (APC/CCdh1),	 is	 stabilized	 in	 E1KDs	 compared	 to	 NMuMGs	 (Fig.	 9).	 Furthermore,	expression	 of	 the	 APC/CCdc20	 substrate,	 securin,	 is	 diminished	 in	 E1KDs	 compared	 to	NMuMGs	 (Fig.	 9).	 The	 specificity	 of	 the	 APC/C	 for	 cyclin	 A	 remains	 unclear,	 and	 its	expression	level	does	not	vary	between	NMuMG	and	E1KD	cells	(Fig.	9).	The	stabilization	of	Cdh1	 substrates	 and	 decreased	 levels	 of	 Cdc20	 substrates	 led	 us	 to	 look	 at	 expression	levels	 of	 the	 cofactors	 themselves.	 Immunoblot	 analysis	 revealed	 that,	 indeed,	 the	expression	 of	 Cdc20	 is	 constitutively	 high	 in	 E1KDs,	whereas	 Cdh1	 is	 almost	 completely	absent	(Fig.	10A).		
Figure 9
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Figure 9: APC/CCdh1 substrates are stabilized in E1KDs, while
APC/CCdc20 substrates are decreased. Immunoblot analysis of
protein expression of Plk1, Cyclin A, and securin in whole cell lysates
prepared from NMuMG and E1KD cells synchronized by overnight
culturing in DMEM + 0.5% FBS, then release for times indicated in
figure.
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To	 determine	 the	mechanism	whereby	 Cdh1	 expression	 is	 lost	 in	 E1KDs,	we	 first	assessed	 the	 levels	 of	 Cdh1	mRNA	 (gene	 name	 Fzr1).	 Total	 RNA	was	 isolated	 from	 G0-synchronized	NMuMG	and	E1KD	cells,	 then	reverse	transcribed	 into	cDNA	using	oligo-dT	primers.	 Semiquantitative	 PCR	 was	 then	 performed	 using	 primers	 for	 Fzr1.	 Expression	levels	of	Fzr1	appear	to	be	the	same	in	E1KDs	and	NMuMGs	(Fig.	10B).		To	 assess	 whether	 the	 Fzr1	 mRNA	 was	 being	 translated	 into	 protein,	 polysome	profile	 analysis	 was	 repeated.	 Cytosolic	 extracts	 from	 NMuMG	 and	 E1KD	 cells	 were	resolved	on	10-50%	sucrose	gradients	and	total	RNA	was	isolated	from	discrete	fractions.	The	 RNA	 was	 reverse-transcribed	 into	 cDNA,	 and	 then	 semi-quantitative	 PCR	 was	performed	to	assess	sedimentation	of	Fzr1	mRNA.	According	to	the	results,	Fzr1	sediments	to	the	heavy,	polysomal	fractions	in	both	NMuMG	and	E1KD	cells	(Fig.	10C).		
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Figure 10: Cdh1 expression is lost in E1KDs. (A) Immunoblot analysis of
expression of Cdc20 and Cdh1 in whole cell lysates prepared from G0-
synchronized NMuMG and E1KD cells. (B) Semi-quantitative RT-PCR analysis
with gene specific primers to Fzr1 using total RNA isolated from G0-synchronized
NMuMG and E1KD cells. (C) Semi-quantitative RT-PCR analysis using gene-
specific primers to Fzr1 using RNA isolated from polysome profiling of NMuMG
and E1KD cytosolic extracts.
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Finally,	we	wanted	to	investigate	whether	proteasomal	degradation	was	responsible	for	 the	decreased	 levels	of	Cdh1	protein	observed	 in	E1KD	cells.	NMuMG	and	E1KD	cells	were	treated	with	the	26S	proteasome	inhibitor,	MG-132,	at	a	concentration	of	10	µM	for	1	hour.	 Cdh1	 expression	 was	 rescued	 in	 the	 E1KD	 cells	 treated	 with	 MG-132	 (Fig.	 11).	Expression	of	hnRNP	E1	 is	 shown	 to	validate	 the	knockdown	of	hnRNP	E1	 in	E1KD	cells	and	GAPDH	is	shown	as	a	loading	control	(Fig.	11).		The	SCF	E3	ubiquitin	ligase	bound	to	 its	 cofactor,	 β-TRCP	 (SCFβ-TRCP)	 is	responsible	 for	 canonical	 degradation	 of	Cdh1during	 the	 cell	 cycle.	 To	 assess	 the	activity	 of	 the	 SCF,	 we	 analyzed	expression	levels	of	its	substrates.	Briefly,	cell	 lysates	were	 prepared	 from	NMuMG	and	 E1KD	 cells	 that	 had	 been	synchronized	at	G0	and	re-stimulated.	Lysates	were	resolved	by	SDS-PAGE,	transferred	to	PVDF	membrane,	and	immunoblot	analysis	was	performed.	β-catenin	is	a	target	of	the	SCFβ-
TRCP,	and	 its	expression	 is	markedly	 increased	 in	E1KDs	(Fig.	12).	The	cell	cycle	 inhibitor,	p27,	 is	 a	 target	 of	 the	 SCF	 bound	 to	 another	 cofactor,	 Skp2,	 and	 its	 expression	 is	 also	elevated	 in	 E1KD	 cells	 (Fig.	 12).	 The	 levels	 of	 both	 SCF	 cofactors,	β-TRCP	 and	 Skp2,	 are	decreased	in	E1KDs	(Fig.	12).		
The	 APC/CCdc20	 is	 constitutively	 active	 in	 E1KD	 cells	 and	 can	 ubiquitinate	
recombinant	 Cdh1	 in	 vitro.	 Because	 other	 SCF	 substrates	 were	 not	 also	 being	
Figure 11
IB: Cdh1
IB: hnRNP E1
- + - +
NMuMG E1KD
IB: GAPDH
10uM
MG132
Figure 11: Cdh1 is proteasomally degraded
in E1KD cells. Immunoblot analysis of protein
expression in whole cell lysates prepared from
NMuMG and E1KD cells treated -/+ 10 uM
MG132 for 1 hour using anti-Cdh1, anti-hnRNP
E1, and anti-GAPDH (control) antibodies.
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constitutively	degraded	 in	E1KD	cells	 like	Cdh1,	we	wanted	 to	 investigate	 the	possibility	that	another	E3	ubiquitin	ligase	could	target	Cdh1	in	E1KDs.	NMuMG	and	E1KD	cells	were	treated	with	 the	APC/C	 inhibitor	proTame	 for	up	 to	6	hours	and	whole	cell	 lysates	were	prepared	 at	 indicated	 time	 points	 (Fig.	 13A).	 Lysates	 were	 resolved	 by	 SDS-PAGE	 and	transferred	to	PVDF	membrane.	Immunoblot	analysis	was	performed	and	the	expression	of	Cdh1	appears	to	be	rescued	in	E1KDs	treated	with	proTame	up	to	3	hours.	Both	NMuMG	and	E1KD	cells	exhibit	a	decrease	in	Cdh1	at	6	hours	of	proTame	treatment	(Fig.	13A).		To	 determine	 whether	 the	 APC/C	 was	 responsible	 for	 Cdh1	 degradation,	 in	 vitro	ubiquitination	 assay	 was	 performed	 using	 APC/C	 affinity-purified	 from	 NMuMGs	 and	E1KDs	synchronized	in	either	M	phase	or	G1	phase	using	thymidine-nocodazole	block	and	release,	 respectively.	 Cell	 extracts	were	 prepared	 in	 ubiquitin	 lysis	 buffer	 and	 incubated	with	 and	α-Cdc16	antibody	 that	had	been	 conjugated	 to	Protein	G	Sepharose	beads.	 The	immunopurified	APC/C	E3	ligase	was	then	incubated	with	recombinant	myc-tagged	Cyclin	B	(residues	1-220)	or	recombinant	GST-Cdh1	in	the	presence	of	E1-activating	enzyme,	E2-
Figure 12
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Figure 12: The ubiquitin ligase activity of the SCF is not elevated in
E1KD cells. Immunoblot analysis of protein expression in whole cell lysates
prepared from G0-synchronized and released NMuMG and E1KD cells
using antibodies recognizing beta-Catenin, p27, beta-TRCP, and Skp2.
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conjugating	 enzymes,	 and	 1X	 ubiquitin	 reaction	 buffer.	 Reactions	 were	 stopped	 after	 1	hour	 by	 addition	 of	 Laemmli	 sample	 buffer	 and	 then	 resolved	 by	 SDS-PAGE.	 After	transferring	 to	 PVDF	 membrane,	 immunoblot	 analysis	 was	 performed	 using	 α-Myc	 tag	antibody	 or	α-GST	 tag	 antibody.	 Recombinant	myc-tagged	 cyclin	 B	was	 ubiquitinated	 by	mitotic	 APC/C	 isolated	 from	 NMuMGs,	 and	 in	 both	mitotic	 and	 G1	 APC/C	 isolated	 from	E1KD	 cells	 (Fig.	 13B,	 left).	 Recombinant	 GST-Cdh1	 was	 ubiquitinated	 by	 mitotic	 APC/C	isolated	 from	NMuMGs	and	by	both	G1	and	mitotic	APC/C	 isolated	 from	E1KD	cells	 (Fig.	13B,	right).	
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Figure 13: APC/CCdc20 is constitutively active in E1KDs and
can ubiquitinate GST-Cdh1 in vitro. (A) Immunoblot analysis of
protein expression of Cdh1 and Hsp90 (control) in NMuMG and
E1KD cells treated with the APC/C inhibitor proTAME for times
indicated. (B) Immunoblot analysis of ubiquitination shifts of
recombinant Myc-Cyclin B (residues 1-102) left, and GST-Cdh1
right resulting from in vitro ubiquitination reactions using APC/C
immunopurified from mitotic and G1 NMuMG and E1KD cells,
synchronized using thymidine-nocodazole block and release.
 46	
In	 order	 to	 determine	 whether	 aberrant	 expression	 of	 Cdc27	 was	 involved	 in	premature	 activation	 of	 the	 APC/CCdc20,	 NMuMG	 cells	 were	 transfected	 with	 a	 plasmid	expressing	Flag-tagged	Cdc27,	now	referred	to	as	NMuMG-Cdc27	cells.	Expression	levels	of	Cdc27	 are	 shown	 in	NMuMG,	 E1KD,	 and	NMuMG-Cdc27	 cells	 and	GAPDH	was	 used	 as	 a	loading	control	(Fig.	14A).	NMuMG,	E1KD,	and	NMuMG-Cdc27	cells	were	synchronized	 in	mitosis	 using	 thymidine-nocodazole	 block,	 then	 released	 into	 G1.	 Cell	 lysates	 were	prepared	 at	 indicated	 time	 points	 and	 resolved	 by	 SDS-PAGE.	 Immunoblot	 analysis	 of	expression	of	Cdh1	in	the	three	cell	lines	revealed	that	NMuMG-Cdc27	cells	expressed	Cdh1	at	levels	similar	to	E1KD	cells	(Fig.	14B).	To	confirm	synchronization	and	exit	from	mitosis,	levels	of	phosphorylated	histone	H3	are	shown	(Fig.	14B).		
Loss	 of	 hnRNP	 E1	 or	 overexpression	 of	 Cdc27	 results	 in	 increased	 G2/M	
population	 and	 increased	 variability	 in	 chromosome	 number.	 E1KD-shCdc27	 cells	were	 developed	 in	 the	 laboratory	 and	 knockdown	 of	 Cdc27	 expression	 is	 shown	 by	immunoblot	 analysis	 of	 lysates	 prepared	 from	 NMuMG,	 E1KD,	 and	 E1KD-shCdc27	 cells	(Fig.	 15A).	 To	 investigate	 the	 contribution	 of	 Cdc27	 to	 cell	 cycle	 distribution,	 cell	 cycle	
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Figure 14: Overexpression of Cdc27 alone results in decreased
levels of Cdh1. (A) Immunoblot analysis of Cdc27 and GAPDH (control)
protein expression in NMuMG, E1KD, and NMuMG-Cdc27 cells. Flag-
tagged Cdc27 is shifted up due to the molecular weight of the tag.
(B) Immunoblot analysis of Cdh1 and phospho-histone H3 protein
expression in NMuMG, E1KD, and NMuMG-Cdc27 whole cell lysates
prepared from cells synchronized by thymidine-nocodazole block and release.
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profile	 analyses	 of	 NMuMG,	 E1KD,	 NMuMG-Cdc27,	 and	 E1KD-shCdc27	 cells	 were	performed	 using	 propidium	 iodide	 staining	 of	 total	 cellular	 DNA	 followed	 by	 flow	cytometric	analysis.	A	larger	percentage	of	E1KD	and	NMuMG-Cdc27	cells	were	found	to	be	present	in	G2/M	compared	to	NMuMGs	and	E1KD-shCdc27	cells	(Fig.	15B).				
In	 order	 to	 further	 investigate	 the	 G2/M	 arrest	 observed	 in	 these	 cells,	 we	performed	immunofluorescent	confocal	microscopy	of	NMuMG,	E1KD,	and	NMuMG-Cdc27	cells,	 staining	 for	α-Tubulin,	 hnRNP	E1,	 and	DAPI	 (Fig.	 16A).	We	observed	many	mitotic	abnormalities	 such	 as	 metaphase	 plates	 with	 misaligned	 chromosomes	 and	 amplified	centrosome	 numbers	 in	 E1KD	 and	NMuMG-Cdc27	 cells	 that	were	 absent	 in	 the	NMuMG	control	cells	(Fig.	16B).		To	 determine	 whether	 the	 observed	mitotic	 aberrations	 were	 giving	 rise	 to	 cells	with	 aneuploid	 chromosome	 numbers,	 at	 least	 50	 metaphases	 from	 NMuMG,	 E1KD,	
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Figure 15: Modulating Cdc27 expression affects cell cycle
distribution of NMuMG and E1KD cells. (A) Immunoblot analysis
of Cdc27 and GAPDH (control) protein expression in NMuMG,
E1KD, and E1KD-shCdc27 cells. (B) Cell cycle distribution analysis
of NMuMG, E1KD, NMuMG-Cdc27, and E1KD-shCdc27 cells based
on results of propidium iodide staining followed by flow cytometric
measurement of cellular DNA content.
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NMuMG-Cdc27,	 and	 E1KD-shCdc27	 cells	 were	 counted.	 Representative	 images	 of	metaphase	 chromosome	spread	preparations	 stained	with	DAPI	are	 shown	on	 the	 left	 in	Figure	5D.	E1KD	cells	had	significantly	(P=0.032)	higher	numbers	of	aneuploid	metaphases	compared	to	NMuMGs	as	determined	by	unpaired	Student’s	t-test	(Fig.	17).	Approximately	58%	 of	 NMuMG-Cdc27	 metaphases	 counted	 had	 aneuploid	 chromosome	 numbers,	however	 the	data	was	not	statistically	significant	when	compared	 to	NMuMG	controls	by	unpaired	 Student’s	 t-test	 (P=0.215).	 Finally,	 72%	 of	 the	 E1KD-shCdc27	 metaphases	counted	had	aneuploid	chromosome	numbers.		
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Figure 16: Mitotic aberrations occur in E1KD and NMuMG-
Cdc27 cells. Immunofluorescence confocal microscopy images
of representative mitoses of NMuMG, E1KD, and NMuMG-Cdc27
cells stained with DAPI (blue), alpha-Tubulin (green), and hnRNP
E1 (red). Magnification is 120X.
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Cdc27	 is	 up	 regulated	 and	 Cdh1	 is	 down	 regulated	 in	 in	 vivo	 selected	
metastasis	 model.	 The	 model	 describing	 the	 generation	 of	 in	 vivo-selected	 metastatic	E1KD	cells	is	shown	in	Figure	18.	Characterization	of	the	isolated	cells	in	vitro	revealed	that	L2P	cells	had	the	highest	migratory	(Fig.	19A)	and	invasive	(Fig.	19B)	phenotype	compared	to	 E1KD,	M1P,	 and	 L1P	 cell	 lines	 as	 assessed	 by	 in	 vitro	migration	 and	 in	 vitro	 invasion	studies.	Semi-quantitative	RT-PCR	analysis	of	NMuMG,	E1KD,	M1P,	L1P,	and	L2P	cells	was	performed	to	validate	the	identity	of	the	cells	isolated	from	mice	using	primers	specific	to	
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Figure 17: Modulating hnRNP E1 or Cdc27 expression induces
chromosomal instability. Representative images of metaphase
spreads prepared from NMuMG, E1KD, NMuMG-Cdc27, and E1KD-
shCdc27 cells using DAPI to stain chromosomes. Magnification is
120X. Quantification of percent of aneuploid cells in populations.
(n=50; Student’s t-Test, * P < 0.05, ** P < 0.001)
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the	sequence	of	the	pSilencer	plasmid	and	Actb	was	used	as	a	loading	control	(Fig.	20).	The	process	of	 in	vivo	 selection	of	metastatic	E1KD	cells	resulted	 in	a	slight	 increase	 in	Cdc27	mRNA	 expression	 and	 a	 large	 decrease	 in	 Fzr1	 mRNA	 expression	 (Fig.	 20).	 The	 level	 of	expression	 of	 Cdh1	 protein	was	 also	 decreased	 in	M1P,	 L1P,	 and	 L2P	 cells	 compared	 to	E1KD	cells	(Fig.	20).		
In	vivo	selection	of	E1KD	cells	leads	to	a	higher	percentage	of	cells	present	in	
G2/M	 and	 a	 higher	 rate	 of	 aneuploidy.	Propidium	 iodide	 staining	and	 flow	cytometry	
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Figure 18: Model of E1KD Progression Series Isolation 50k E1KD cells were injected into the inguinal mammary
fat pads of female NOD/SCID mice, then allowed to form tumors. Mice were euthanized at 15 weeks post-injection
and primary tumors were enzymatically digested and cells cultured (M1P). Lungs were also enzymatically digested
and grown in culture medium plus selection antibiotics (L1P). 50k L1P cells were injected into inguinal mammary
fat pads of female NOD/SCID mice, allowed to form tumors, and mice were euthanized after 5 weeks due to
significant morbidity. Lung metastases isolated from these mice were called L2P.
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were	performed	using	fixed	NMuMG,	E1KD,	M1P,	L1P,	and	L2P	cells.	The	Dean-Jett	model	of	DNA	distribution	was	utilized	to	analyze	cell	cycle	profiles	of	cell	lines.	G2/M	populations	of	L1P	and	L2P	cells	were	higher	than	NMuMG,	E1KD,	or	M1P	cells	(Fig.	21A).	Metaphase	
Figure 19: In vivo passaging of E1KD cells results in increased migratory and invasive
capability, as well as increased ability to colonize lung tissue. (A) Representative image of
stained and fixed cells following in vitro migration assay using E1KD, M1P, L1P, and L2P. (B)
Representative images of in vitro invasion assay using NMuMG, E1KD, M1P, L1P, and L2P cells.
(C) Representative images of formalin-fixed paraffin-embedded lungs of NOD/SCID mice that
had E1KD, L1P, or L2P cells injected via tail vein that have been stained using H&E. Arrows
indicate metastatic lesions.
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spreads	were	prepared	from	M1P,	L1P,	and	L2P	cells	and	compared	to	NMuMG	and	E1KD	spreads.	 Representative	 images	 of	 DAPI-stained	 metaphase	 spreads	 and	 average	chromosome	 number	 ±	 S.E.M.	 are	 shown	 in	 Figure	 20.	 L1P	 and	 L2P	 cells	 consistently	exhibited	 a	 higher	 rate	 of	 aneuploidy	 than	 E1KD	 and	M1P	 cells,	 resulting	 in	 a	 loss	 of	 2	chromosomes	for	an	average	chromosome	number	of	38	(Fig.	21B).		
High	Cdc27	expression	and	high	mitotic	indices	predict	metastatic	potential	in	
breast	 cancer	 cell	 lines.	 In	 order	 to	 validate	 the	 significance	 of	 our	 findings	 in	 human	disease,	we	 first	wanted	 to	 investigate	 expression	 of	 Cdc27	 in	 normal	 human	mammary	epithelial	 cells	 and	 human	 breast	 cancer	 cell	 lines.	 Human	 mammary	 epithelial	 cells	(HMLE)	were	used,	as	they	contain	two	subpopulations	of	cells:		a	non-invasive,	epithelial	subtype	 (HMLE-epithelial)	 and	 a	 stably	 transitioned,	 mesenchymal	 subtype	 (HMLE-mesenchymal)	 that	 exhibit	 invasive	 and	 metastatic	 characteristics.	 We	 also	 developed	hnRNP	E1-knockdown	HMLE-epithelial	 cells	 in	our	 laboratory,	 termed	HMLE-E1KD	cells.	Other	breast	cancer	cell	lines	were	also	assayed,	including	MCF7,	MDA-MB-231,	MDA-MB-468,	 T47D,	 and	 BT-20.	 Whole	 cell	 lysates	 were	 prepared	 and	 resolved	 by	 SDS-PAGE.	
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Figure 20: Validation of Identity of E1KD Progression Series Cells. (A) Semi-
quantitative RT-PCR from total RNA isolated from NMuMG, E1KD, M1P, L1P, L2P
cells using gene-specific primers to pSilencer plasmid, Cdc27, Fzr1, and Actb (control).
(B) Immunoblot analysis of whole cell lysates isolated from NMuMG, E1KD, M1P, L1P,
and L2P cells using antibodies recognizing hnRNP E1, Cdc27, Cdh1, and GAPDH (control).
 53	
Immunoblot	 analysis	 shows	 that	 both	 Cdc27	 and	 Cdh1	 expression	 is	 increased	 in	 the	HMLE-mesenchymal	 and	 HMLE-E1KD	 cell	 lines	 compared	 to	 HMLE-epithelial	 cells;	expression	of	hnRNP	E1	is	shown	to	validate	the	knockdown	in	HMLE-E1KD	cells;	GAPDH	
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Figure 21: In vivo selection results in increased G2/M population
and increased aneuploidy. (A) Cell cycle distributions of NMuMG,
E1KD, M1P, L1P, and L2P cells based on propidium iodide staining
followed by flow cytometric analysis. Percentages were calculated
based on Dean-Jett mathematical model of DNA distribution.
(B) Representative images of DAPI-stained metaphase spreads
prepared from M1P, L1P, and L2P cells. Average chromosome counts
are displayed -/+ S.E.M. 45 metaphases were counted per cell line.
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is	 used	 as	 a	 loading	 control	 (Fig.	 22A,	 left	 panels).	 Expression	 of	 Cdc27	 and	 Cdh1	 are	highest	in	both	MCF7	and	MDA-MB-231	cells	compared	to	MDA-MB-468,	BT20,	and	T47D	cells;	 hnRNP	 E1	 expression	 is	 similar	 between	 all	 breast	 cancer	 cell	 lines	 and	 GAPDH	expression	is	shown	as	a	loading	control	(Fig.	22A,	right	panels).		Analysis	 of	 cell	 cycle	distribution	 was	 performed	 using	propidium	iodide	staining	of	total	DNA	followed	 by	 flow	 cytometry.	 HMLE-mesenchymal	 and	 HMLE-E1KD	 cells	both	 had	 higher	 percentages	 of	 G2/M	cells	 compared	 to	 HMLE-epithelial	cells.	MCF7	and	MDA-MB-231	cells	had	the	 highest	 proportion	 of	 G2/M	 cells	compared	to	other	breast	cancer	cell	lines.	Finally,	to	quantify	aneuploidy	in	breast	cancer	cell	 lines,	metaphase	spreads	were	prepared	 from	cells	and	at	 least	35	metaphases	were	counted	per	cell	line.	Representative	images	of	metaphases	are	shown	in	Figure	23.	Results	were	 quantified	 and	 presented	 as	 average	 chromosome	 count	 ±	 S.E.M.	 HMLE-epithelial	cells	 were	 compared	 to	 HMLE-mesenchymal	 and	 HMLE-E1KD	 cells,	 and	 HMLE-mesenchymal	 cells	 exhibited	 significant	 aneuploidy	 compared	 to	 HMLE-epithelial	 cells,	while	 HMLE-E1KD	 cells	 exhibited	 aneuploidy,	 but	 the	 data	 was	 not	 significant	 (Fig.	 23,	graph).	MCF7,	BT20,	and	T47D	cell	lines	exhibited	the	highest	amount	of	aneuploidy	with	chromosome	numbers	of	approximately	3n	(Fig.	23,	graph).		
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Figure 22: Cdc27 expression is increased in some
breast cancer cell lines. Immunoblot analysis of protein
expression in whole cell lysates isolated from breast
cancer cell lines using antibodies recognizing Cdc27,
Cdh1, hnRNP E1, and GAPDH (control).
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Tissue	 microarray	
analysis	 of	 breast	 cancer	
patient	 samples	 reveals	
that	high	Cdc27	expression	
in	 tumor	 samples	 is	 a	
predictor	 of	 recurrence.	Breast	 cancer	 patient	 tissue	microarrays	were	assembled	and	stained	for	Cdc27	by	the	Hollings	 Cancer	 Center	Tissue	Biorepository	as	described	above.	A	second	investigator	blinded	to	sample	type	and	clinicopathological	 data	 performed	 independent	 scoring.	 Tissue	 sample	 staining	 was	scored	 on	 a	 scale	 of	 0	 (low/negative	 staining)	 to	 3	 (intense	 staining).	 Significance	 was	determined	 by	 Student’s	 t-test.	 Scoring	 of	 TMA	 samples	 revealed	 that	 significantly	(P<0.001)	higher	Cdc27	staining	was	present	 in	 tumor	 tissue	 compared	 to	normal	 tissue	(Fig.	24).	Kaplan	Meier	 survival	 analysis	was	performed	using	patient	data	provided	and	results	indicated	that	high	Cdc27	score	significantly	predicted	a	higher	incidence	of	disease	recurrence	when	compared	to	low	Cdc27	score	(Log	rank	P	=	0.046)	(Fig.	25).		Tissue	microarray	analysis	was	performed	using	Cdh1	antibody	and	the	same	breast	cancer	 patient	 samples	 that	were	 analyzed	 for	 Cdc27	 expression.	 Expression	 of	 Cdh1	 in	breast	cancer	patient	tumor	tissue	was	significantly	higher	than	in	normal	tissue	(P<0.001)	(Fig.	 26A).	 In	 tumor	 lymph	 node	 samples,	 5	 out	 of	 6	 patients	 with	 low	 Cdh1	 score	
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Figure 23: Percent of breast cancer cell line G2/M populations
are highest in cell lines expressing highest levels of Cdc27. Cell
cycle distributionsof breast cancer cell populations are shown, based
on propidium iodide staining followed by flow cytometric analysis of
total DNA content, corresponding to cell cycle phase.
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experienced	 disease	 recurrence,	 while	 only	 2	 out	 of	 8	 of	 those	 with	 high	 Cdh1	 score	experienced	recurrence	(Fig.	26B,	Table	4).		
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Figure 24: Breast cancer cell lines exhibit high amounts of
aneuploidy. Representative images of metaphase spreads prepared
from breast cancer cell lines using DAPI to stain chromosomes.
Quantitation of average number of chromosomes -/+ SEM are shown
below. (n=35; Student’s t-Test, * P < 0.05)
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Figure 25: High Cdc27 score in breast cancer tumor patient samples
significantly predicts recurrence of metastatic disease. (A) Representative
images of immunohistological Cdc27 staining normal and tumor tissue isolated
from breast cancer patients. Scoring of normal versus tumor is shown on the
right (n=32; Student’s t-Test, P < 0.001). (B) Representative images of high and
low-score immunohistological Cdc27 staining in breast cancer patient tumor samples.
Kaplan-Meier survival plot is shown on the right with High Cdc27 score significantly
predicting disease recurrence (Log Rank P < 0.05).
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Figure 26: Cdh1 staining is signficantly higher in breast cancer
patient tumor samples compared to normal. Representative images
of Cdh1 immunohistological staining of tissue microarray samples from
normal and tumor tissue isolated from breast cancer patients. Scoring of
normal versus tumor is shown on the right. (n=33; Student’s t-Test, P < 0.001).
(B) Representative images of immunohistochemical staining of formalin-fixed
paraffin-embedded tissue microarray samples from breast cancer patient tumor
lymph nodes.
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Patient Vital Status Recurrence Days to Recurrence 
Days to Death or 
Most Recent 
Contact 
1335 Deceased No   2713 
1351 Alive Yes 178 235 
1356 Deceased No   2916 
1360 Alive Yes 1802 2887 
1373 Deceased Yes 
0 (prior surgery for ductal 
carcinoma in situ) 3022 
1389 Deceased Yes 806 2799 
1420 Alive Yes 373 474 
1441 Deceased No   2679 
1459 Deceased unknown   2666 
1484 Alive Yes 326 784 
1773 Deceased No   2365 
1968 Alive Yes 485 749 
2501 Deceased No   1811 
2601 Alive Yes 1101 1558 
3565 Deceased unknown   1312 
4065 Deceased unknown   1004 
4215 Deceased No   1132 
4368 Deceased No   1036 
4555 Deceased unknown   841 
4594 Deceased No   582 
4673 Deceased No   574 
4684 Deceased No   534 
4692 Deceased No   492 
5010 Deceased No   468 
5076 Deceased No   388 
5108 Deceased No   386 
5116 Deceased unknown   142 
5126 Deceased No   498 
5219 Deceased No   491 
5317 Deceased No   182 
5428 Deceased Yes   197 
5615 Deceased No   11 
 
Table 2:  Tissue Microarray Breast Cancer Patient Survival Data  
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Patient Tumor Lymph Node Cdh1 Score Recurrence 
1335 Low No 
1373 Low Yes 
1389 Low Yes 
1420 Low Yes 
1968 Low Yes 
2601 Low Yes 
1351 High Yes 
1356 High No 
1484 High Yes 
4065 High Unknown 
4555 High Unknown 
4594 High No 
4692 High No 
5126 High No 
 
Table 3:  Breast cancer patient tumor lymph node scoring and corresponding 
survival data. Low Cdh1 score in 83% of tumor lymph node samples was found to 
occur in patients who experienced metastatic recurrence, whereas high Cdh1 score in 
only 25% of tumor lymph node samples was found to occur in patients who experienced 
metastatic recurrence. 
 61	
Figure 15
RAC
Cdc42
pRAC
pCdc42
Pak1 pPak1
hnRNP E1 phnRNP E1
G1 S G2/M
Low Cdc27 High Cdc27
APC/CCdh1 APC/CCdc20
Growth Factors,
Hormones
Growth Factor Receptors
Hormone Receptors
Figure 24: Model of hnRNP E1-mediated regulation of APC/C function
through post-transcriptional regulation of Cdc27 expression.During G1,
Cdc27 expression is low due to binding of hnRNP E1 to its mRNA.Activation
of Rac/Cdc42 after the G1/S transition leads to phosphorylation and activation
of Pak1, followed by phosphorylation of hnRNP E1 and its subsequent release
from Cdc27 mRNA. Cdc27 expression is highest during mitosis, when APC/C-
Cdc20 is active and APC/CCdh1 is inactive. We hypothesize that APC/CCdc20
regulates the levels of Cdh1 by ubiquitinating it, tagging it for 26S proteasome
mediated degradation.
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V.		Chapter	5:		Discussion		 	To	 elucidate	 other	 biological	 pathways	 in	 which	 hnRNP	 E1	 is	 involved,	 the	 non-TGFβ-dependent	 transcripts	 identified	were	 functionally	annotated	using	DAVID	Webtool	(Dennis	 et	 al.,	 2003;	 Huang	 da,	 Sherman,	 &	 Lempicki,	 2009)	 to	 determine	 whether	 any	biological	 pathways	 were	 enriched	 in	 the	 gene	 set.	 The	 cutoff	 for	 change	 in	 expression	between	NMuMG	monosomes	and	E1KD	polysomes	was	1.5-fold.	Results	of	DAVID	analysis	are	shown	in	Figure	1A.	Nucleic	acid	metabolism	was	highly	enriched,	as	well	as	cell	cycle	(P<0.05).	 It	has	been	shown	previously	that	hnRNP	E1	is	 involved	in	mRNA	transcription	(Chaudhury,	Chander,	et	al.,	2010;	Meng	et	al.,	2007;	Ostareck-Lederer	et	al.,	1998;	Xia	et	al.,	2012),	so	its	presence	in	the	results	of	the	analysis	was	expected.		We	 chose	 to	 further	 investigate	 the	 cell	 cycle	 genes	 that	 were	 translationally	regulated	by	hnRNP	E1.	The	loss	of	cell	cycle	regulation	is	one	of	the	hallmarks	of	cancer	progression	(Hanahan	&	Weinberg,	2000,	2011).	The	consequences	of	defects	in	regulation	of	 cell	 cycle	 include,	 but	 are	 not	 limited	 to,	 defective	 DNA	 damage	 repair,	 aneuploidy,	proliferation	 in	 the	 absence	 of	 mitogenic	 stimulation,	 and	 insensitivity	 to	 anti-growth	signaling	 (Hanahan	 &	 Weinberg,	 2000,	 2011),	 all	 of	 which	 have	 been	 attributed	 to	 the	progression	 of	 cancer	 and	 metastasis.	 Within	 the	 group	 of	 hnRNP	 E1-regulated	 genes	involved	 in	 cell	 cycle,	we	 decided	 to	 further	 investigate	Cdc27	 because	 of	 its	 role	 in	 the	anaphase-promoting	 complex/cyclosome	 (APC/C).	 Cell	 division	 cycle	 27	 (Cdc27),	 also	known	as	APC3,	is	a	core	component	of	the	APC/C.	During	the	cell	cycle,	the	APC/C	plays	a	critical	 role	 in	 facilitating	 the	 metaphase-to-anaphase	 transition,	 as	 well	 as	 preventing	premature	S-phase	entry	during	G1	(Peters,	2002,	2006).		
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According	 to	 the	 model	 elucidated	 previously	 by	 our	 laboratory	 for	 hnRNP	 E1-mediated	 translational	 silencing	 (Chaudhury,	 Hussey,	 et	 al.,	 2010;	 Hussey	 et	 al.,	 2011),	hnRNP	 E1	 binds	 the	 3’UTR	 of	 the	mRNA	 as	well	 as	 EF1A1	 in	 the	 ribosomal	 A	 site.	 This	interaction	 between	 hnRNP	 E1	 and	 EF1A1	 prevents	 the	 release	 of	 EF1A1	 from	 the	ribosome,	stalling	translation	at	the	elongation	step.	The	sedimentation	of	Cdc27	mRNA	to	the	 60S	 and	 80S	 ribosomal	 fractions	 suggests	 that	 translation	 is	 initiating,	 but	 not	occurring,	possibly	due	 to	stalled	elongation	 in	 the	presence	of	hnRNP	E1.	There	 is	some	
Cdc27	 present	 in	 the	 polysome	 fractions	 in	 NMuMG	 cells.	 This	 could	 be	 because	 Cdc27	expression	 is	dependent	on	 cell	 cycle	phase,	 and	 the	 cells	used	 for	 this	 experiment	were	asynchronous.	Those	cells	in	later	stages	of	the	cell	cycle	are	actively	translating	Cdc27,	as	I	will	show	in	the	next	figure.	Cdc27	mRNA	is	present	primarily	in	the	polysome	fractions	of	E1KD	cells	(Fig.	2B).	According	to	the	model	of	hnRNP	E1-mediated	translational	silencing,	in	 the	 absence	 of	 hnRNP	 E1,	 Cdc27	 mRNA	 will	 be	 constitutively	 translated.	 The	 results	support	 the	 model	 of	 hnRNP	 E1-mediated	 translational	 silencing.	 Translation	 of	 Actb	 is	shown	below	Cdc27	as	a	control	 to	show	that	global	 translation	 is	not	 increased	 in	E1KD	cells	(Fig.	2B).	The	absorbance	profiles	of	NMuMG	and	E1KD	polysome	analyses	are	shown	below	the	PCR	results	to	further	provide	evidence	that	global	translation	is	similar	between	NMuMG	and	E1KD	cells	(Fig.	2B,	lower).		Because	 of	 its	 role	 as	 a	 core	 component	 of	 a	 complex	 regulating	 cell	 cycle	progression,	 we	 hypothesized	 that	 expression	 of	 Cdc27	 might	 occur	 in	 a	 cell	 cycle-dependent	manner	 in	normal	 cells.	 Indeed,	we	 found	 that	 Cdc27	 expression	 increases	 at	the	 protein	 level	 and	 not	 the	 transcript	 level	 during	 cell	 cycle	 progression,	 further	
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supporting	the	hypothesis	that	Cdc27	expression	is	regulated	post-transcriptionally	in	the	presence	of	hnRNP	E1.			 In	 order	 to	 show	 that	 Cdc27	 expression	 is	 induced	 at	 the	 translational	 level	 after	mitogenic	 stimulation,	 polysome	 profile	 analysis	 was	 performed	 using	 synchronized	NMuMG	and	E1KD	cells.	In	the	G0-synchronized	NMuMG	cells	(0h),	Cdc27	mRNA	is	present	in	the	60S	and	80S	fractions,	corresponding	to	little	or	no	translation.	After	re-stimulation	with	 complete	 medium	 for	 18	 hours,	 Cdc27	 mRNA	 shifts	 to	 the	 polysomal	 fractions,	suggesting	 an	 increased	 rate	 of	 translation	 (Fig.	 5A).	 There	 is	 some	Cdc27	mRNA	 in	 the	polysome	fractions	at	0h.	This	can	be	explained	by	the	incomplete	synchronization	of	the	cell	population	by	 low	serum.	While	nearly	75%	of	 the	cells	are	synchronized	 in	G1	after	overnight	low	serum-culture,	some	cells	are	still	present	in	the	later	phases	of	the	cell	cycle.	In	 the	 E1KD	 cells,	Cdc27	mRNA	 is	 present	 in	 the	 polysome	 fractions	 independent	 of	 cell	cycle	phase	(Fig.	5A).	This	data	suggests	that	Cdc27	mRNA	translation	is	both	cell	cycle-	and	hnRNP	E1-dependent.	Mitogenic	signaling	is	sufficient	to	induce	expression	of	Cdc27	at	the	protein	level	in	NMuMGs.			 The	evidence	for	association	between	hnRNP	E1	and	Cdc27	up	to	this	point	has	been	indirect:		the	absence	of	hnRNP	E1	leads	to	an	increase	in	Cdc27	translation,	independent	of	cell	cycle	phase.	In	order	to	determine	whether	hnRNP	E1	was	interacting	directly	with	
Cdc27	mRNA,	RNA	immunoprecipitation	was	performed.	NMuMG	cells	were	synchronized	using	double	thymidine	block.	This	method	was	utilized	instead	of	G0	synchronization	for	two	reasons:	 	 first,	 it	 is	highly	effective	at	 reversibly	blocking	a	population	of	cells	at	 the	G1/S	transition	(Harper,	2005),	and	second,	the	increase	in	expression	of	Cdc27	protein	in	NMuMGs	 is	 observed	 shortly	 after	 the	 G1/S	 transition	 (Fig.	 2A).	 According	 to	 the	 flow	
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cytometric	analysis	of	cell	cycle	distribution	shown	in	Figure	4,	NMuMG	cells	enter	S	phase	sometime	 between	 12	 and	 18	 hours	 after	 re-stimulation;	 synchronization	 at	 the	 G1/S	transition	 eliminates	 the	 need	 for	 the	 first	 12	 hours	 of	 re-stimulation	 required	 by	 G0-synchronization.	 Based	 on	 the	 results	 of	 the	 RNA	 immunoprecipitation	 assay,	 hnRNP	E1	protein	 binds	 Cdc27	 mRNA,	 and	 this	 interaction	 is	 abolished	 3	 hours	 after	 release	 from	G1/S	arrest	(Fig.	5B).	L1CAM	mRNA	is	shown	as	a	positive	control,	as	others	have	shown	previously	that	its	translation	is	regulated	by	hnRNP	E1	in	a	cell	cycle-dependent	manner	(Meng	et	al.,	2007).	The	interaction	between	L1CAM	and	Cdc27	with	hnRNP	E1	follows	the	same	 pattern,	 suggesting	 that	 their	 interactions	 might	 be	 regulated	 by	 the	 same	mechanism.	 Actb	 is	 included	 as	 a	 negative	 control,	 as	 it	 is	 not	 known	 to	 interact	 with	hnRNP	 E1.	 As	 expected,	 hnRNP	 E1	 does	 not	 immunoprecipitate	 Actb	 mRNA	 (Fig.	 5B).	Immunoprecipitations	were	also	performed	using	IgG	 instead	of	α-hnRNP	E1	antibody	to	ensure	 that	 the	 mRNA	 was	 not	 non-specifically	 associating	 with	 the	 Fc	 regions	 of	 the	hnRNP	E1	antibody.	There	was	some	non-specific	immunoprecipitation	of	Cdc27	mRNA	in	the	 IgG	 immunoprecipitation	 reactions,	 but	 it	 was	 very	 low	 compared	 to	 the	 hnRNP	 E1	immunoprecipitates	and	did	not	follow	the	same	pattern	of	association,	suggesting	that	the	interactions	 observed	 in	 IgG	 immunoprecipitations	 are	 nonspecific.	 Input	 samples	 were	obtained	by	isolating	total	RNA	from	cytosolic	extracts	and	included	to	indicate	that	equal	amounts	of	lysate	and	mRNA	were	present	in	all	immunoprecipitation	reactions.			 The	 cell	 cycle-dependent	 loss	 of	 association	between	hnRNP	E1	 and	Cdc27	mRNA	suggests	that	mitogenic	signaling	functions	upstream	of	hnRNP	E1,	stimulating	its	release	from	 Cdc27	 and	 allowing	 for	 Cdc27	 protein	 expression.	 The	 interaction	 of	 L1CAM	 with	hnRNP	E1	follows	the	same	pattern	as	Cdc27,	suggesting	that	the	two	may	be	regulated	by	
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the	 same	mechanism.	Meng	 et	 al.	 identified	 p21-activated	 kinase	 1	 (Pak1)	 as	 the	 kinase	responsible	 for	 phosphorylating	 hnRNP	 E1	 and	 causing	 its	 release	 from	 L1CAM	 mRNA,	allowing	for	its	translation	(Meng	et	al.,	2007).	To	investigate	whether	the	same	kinase	was	responsible	 for	 expression	 of	 Cdc27	 during	 the	 cell	 cycle,	 we	 first	 wanted	 to	 determine	whether	 mitogenic	 stimulation	 could	 result	 in	 hnRNP	 E1	 phosphorylation,	 and	 also	whether	 this	 phosphorylation	 was	 sensitive	 to	 the	 Pak1	 inhibitor,	 IPA-3.	 IPA-3	 is	 an	allosteric	 inhibitor	 of	 Pak1	 that	 covalently	 binds	 to	 the	 regulatory	 domain	 and	 prevents	binding	of	its	upstream	activator,	Cdc42	(Deacon	et	al.,	2008;	Viaud	&	Peterson,	2009).	To	investigate	 hnRNP	 E1	 phosphorylation	 during	 the	 cell	 cycle,	 hnRNP	 E1	 was	immunoprecipitated	 from	 synchronized	 NMuMG	 whole	 cell	 lysates	 in	 the	 absence	 or	presence	of	30	µM	IPA-3.	The	results	reveal	 that	hnRNP	E1	 is	phosphorylated	at	3	hours	following	 release	 from	 G1/S	 arrest,	 and	 this	 phosphorylation	 event	 is	 absent	 in	 the	presence	of	IPA-3	(Fig.	6A).	The	antibody	used	for	immunoblot	detection	of	phosphorylated	hnRNP	E1	 is	an	HRP-conjugated	antibody	 that	 recognizes	 the	RXXS*/T*	motif,	where	 the	serine	or	threonine	with	an	asterisk	is	phosphorylated.	Pak1	has	been	shown	previously	to	phosphorylate	 residues	 on	 hnRNP	 E1:	 	 threonine	 60	 and	 threonine	 127	 (Chaudhury,	Chander,	et	al.,	2010;	Meng	et	al.,	2007).	Both	threonine	residues	have	an	arginine	at	their	-3	positions,	 suggesting	 that	 this	 antibody	 can	 recognize	Pak1-phosphorylated	hnRNP	E1.	The	 inhibition	of	hnRNP	E1	phosphorylation	 in	 the	presence	of	 IPA-3	as	detected	by	 this	assay	 suggests	 that	 the	 antibody	 is	 recognizing	 Pak1-specific	 phosphorylation	 sites	 on	hnRNP	E1.	 The	membrane	was	 then	 stripped	 and	 re-probed	 for	 total	 hnRNP	E1	 using	 a	different	 antibody	 than	 the	one	used	 for	 immunoprecipitation.	The	amount	of	hnRNP	E1	immunoprecipitated	 at	 all	 time	 points	 was	 equal,	 indicating	 equal	 loading	 of	 lysate	 in	
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immunoprecipitation	 reactions	 and	 also	 indicating	 that	 total	 hnRNP	 E1	 levels	 did	 not	fluctuate	during	G1/S	release	or	in	the	presence	of	IPA-3	(Fig.	6A).	Phosphorylation	of	hnRNP	E1	has	been	shown	previously	to	influence	its	ability	to	bind	RNA	(Chaudhury,	Chander,	et	al.,	2010;	Ostareck	et	al.,	1997;	Ostareck-Lederer	et	al.,	2002;	Ostareck-Lederer	et	al.,	1994).	 In	 this	 study,	we	hypothesize	 that	 the	observed	 the	loss	 of	 hnRNP	 E1	 and	 Cdc27	 interaction	 results	 from	 Pak1-dependent	 hnRNP	 E1	phosphorylation,	 and	 this	 allows	 for	 translation	 of	 Cdc27.	 Immunoblot	 analysis	 of	whole	cell	extracts	that	were	G1/S-arrested	and	released	reveals	that	Cdc27	expression	is	induced	at	 around	 3	 hours	 post-G1/S	 release,	 coinciding	 with	 the	 observed	 phosphorylation	 of	hnRNP	E1	in	Figure	3A	(Fig.	6B).	This	increase	in	Cdc27	expression	is	not	observed	in	the	presence	of	the	Pak1-specific	inhibitor,	IPA-3,	and	the	expression	of	Cdc27	is	constitutively	high	in	E1KDs,	irrespective	of	time	or	presence	of	IPA-3	(Fig.	6B).	This	suggests	that	Cdc27	translation	 is	Pak1-dependent	 in	NMuMG	cells,	while	 the	absence	of	hnRNP	E1	 in	E1KDs	abrogates	 the	 need	 for	 Pak1-mediated	 hnRNP	 E1	 phosphorylation	 to	 induce	 Cdc27	expression.		The	 whole	 cell	 extracts	 were	 further	 analyzed	 for	 Pak1	 phosphorylation,	 which	corresponds	 to	 its	 activation.	 The	 phosphorylation	 of	 Pak1	 is	 at	 its	 highest	 1	 hour	 after	G1/S	 release	 and	 is	maintained	 at	 3	 hours	 (Fig.	 6B).	 The	 kinase	 activity	 of	 Pak1	 is	 itself	regulated	by	phosphorylation,	and	it	has	many	upstream	kinases	including	Cdc42	and	Rac	(Maroto	 et	 al.,	 2008;	 Wang	 et	 al.,	 2006).	 Pak1	 inhibition	 is	 evidenced	 by	 the	 lack	 of	phospho-Pak1	in	the	IPA-3-treated	NMuMG	sample	(Fig.	6B).	In	E1KD	cells,	the	activation	of	Pak1	occurs	in	an	almost	identical	fashion	to	the	NMuMG	cells	and	is	inhibited	in	the	IPA-3-treated	 sample	 (Fig.	 6B).	 This	 suggests	 that	 Pak1	 is	 activated	 in	E1KDs	during	 the	 cell	
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cycle	and	its	activation	is	sensitive	to	IPA-3,	however	the	absence	of	hnRNP	E1	abrogates	the	need	 for	 this	 phosphorylation	 event	 to	 result	 in	 increased	Cdc27	 expression.	 GAPDH	was	included	to	ensure	equal	loading	of	cell	lysate	(Fig.	6B).		To	further	investigate	the	contribution	of	Pak1	to	hnRNP	E1-mediated	translational	silencing	 of	 Cdc27,	 RNA-immunoprecipitation	 was	 performed	 in	 the	 presence	 of	 IPA-3.	NMuMG	 cells	 were	 synchronized	 at	 G1/S	 and	 released	 in	 the	 absence	 or	 presence	 of	increasing	concentrations	of	 IPA-3.	Semi-quantitative	RT-PCR	results	reveal	a	decrease	in	interaction	between	hnRNP	E1	protein	and	Cdc27	mRNA	at	3	hours	post-G1/S-release	(Fig.	7).	 This	 decrease	 in	 interaction	 is	 not	 observed	 in	 the	 presence	 of	 increasing	concentrations	of	IPA-3	(Fig.	7).	This	data	implies	that,	by	inhibiting	phosphorylation	and	subsequent	 activation	 of	 Pak1,	 Pak1-dependent	 phosphorylation	 of	 hnRNP	 E1	 does	 not	occur,	resulting	in	its	stabilization	on	Cdc27	mRNA.	Levels	of	Cdc27	mRNA	remain	constant	during	release	from	G1/S	and	in	the	presence	of	IPA-3,	as	is	evidenced	by	the	input	samples	(Fig.	 7).	 Immunoprecipitations	 with	 IgG	 were	 included	 as	 a	 control	 to	 show	 that	 Cdc27	mRNA	does	not	immunoprecipitate	with	the	Fc	portion	of	the	α-hnRNP	E1	antibody.	There	is	 some	 Cdc27	 mRNA	 present	 in	 the	 IgG	 immunoprecipitates,	 however	 it	 is	much	 lower	than	 the	 input	 and	 α-hnRNP	 E1	 immunoprecipitation	 samples,	 indicating	 that	 the	interaction	is	nonspecific	(Fig.	7).	Actb	is	included	as	it	is	not	a	known	interacting	partner	of	hnRNP	E1,	and	results	indicate	that	it	does	not	immunoprecipitate	with	hnRNP	or	IgG	(Fig.	7),	further	suggesting	that	the	interaction	between	hnRNP	E1	and	Cdc27	is	specific.		Finally,	we	wanted	to	investigate	whether	immunopurified	Pak1	from	synchronized	NMuMG	 cells	 could	 phosphorylate	 recombinant	 GST-hnRNP	 E1	 in	 vitro.	 In	 vitro	phosphorylation	was	performed	by	purifying	Pak1	from	NMuMG	cell	extracts	that	had	been	
 69	
arrested	 by	 double	 thymidine	 block	 and	 released,	 then	 incubating	 the	 immunopurified	Pak1	with	wild-type	 GST-hnRNP	 E1,	 a	 phospho-mutant	 GST-hnRNP	 E1	 developed	 in	 the	laboratory,	 or	 recombinant	 histone	 H4,	 a	 previously	 validated	 target	 of	 Pak1	phosphorylation	(Maroto	et	al.,	2008).	The	phosphomutant	GST-hnRNP	E1	was	developed	by	 sequential	 site-directed	mutagenesis	 of	 the	 two	known	Pak1	phosphorylation	 sites	 in	the	 wild-type	 plasmid.	 Primers	 were	 designed	 to	mutate	 the	 DNA	 sequences	 coding	 for	threonine	60	and	threonine	127	in	the	wild-type	GST-hnRNP	E1	plasmid,	converting	them	both	 to	alanine	 in	 the	new	mutant	plasmid.	Mutation	to	alanine	 is	an	effective	method	 in	rendering	 an	 amino	 acid	 neutral	 to	 phosphorylation.	 The	 immunopurified	 kinase,	recombinant	substrate,	and	γ-[32P]-ATP	were	incubated	together,	reactions	were	resolved	by	 SDS-PAGE	 and	 then	 analyzed	 by	 autoradiography.	 According	 to	 the	 results,	wild-type	GST-hnRNP	E1	and	recombinant	histone	H4	are	phosphorylated	by	immunopurified	Pak1	
in	 vitro,	 while	 the	 phospho-mutant	 GST-hnRNP	 E1	 is	 not	 phosphorylated	 (Fig.	 8).	Furthermore,	the	highest	level	of	phosphorylation	of	wild-type	GST-hnRNP	E1	occurs	when	incubating	with	the	immunopurified	Pak1	from	NMuMGs	that	had	been	released	from	G1/S	arrest	for	3	hours,	coinciding	with	the	previous	results	for	hnRNP	E1	phosphorylation	(Fig.	6A).	These	results	suggest	that	the	threonine	60	and	threonine	127	residues	of	hnRNP	E1	are	necessary	 for	Pak1-mediated	hnRNP	E1	phosphorylation.	There	 is	 a	 small	 amount	of	phosphorylation	of	wild-type	GST-hnRNP	E1	 in	 the	absence	of	 immunopurified	kinase	 in	the	first	 lane	of	the	autoradiography	figure,	however	the	phosphorylation	is	higher	in	the	samples	incubated	with	kinase	and	an	increase	in	phosphorylation	is	apparent	at	3	hours,	indicating	 that	 this	 is	 likely	 background.	 The	 kinetics	 of	 recombinant	 histone	 H4	phosphorylation	 by	 immunopurified	 Pak1	 are	 slightly	 different	 than	 those	 of	 wild-type	
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GST-hnRNP	E1,	however	the	initial	increase	in	phosphorylation	of	both	substrates	occur	at	the	same	time,	suggesting	that	there	may	be	other	modifications	to	Pak1	in	vivo	that	affect	its	kinase	activity	with	regard	to	histone	H4.		We	next	wanted	to	 investigate	the	 impact	 that	constitutively	expressed	Cdc27	had	on	E1KD	cells.	Because	of	its	identity	as	a	core	component	of	the	APC/C,	our	first	goal	was	to	 determine	whether	 the	 function	 of	 the	 APC/C	was	modulated	 in	 E1KDs	 compared	 to	NMuMGs.	The	APC/C	is	an	E3	ubiquitin	ligase	whose	specificity	relies	on	the	presence	of	a	cofactor,	either	Cdc20	or	Cdh1	(Kramer	et	al.,	2000;	Peters,	2002,	2006;	Visintin,	Prinz,	&	Amon,	 1997).	 The	 cofactor-dependent	 substrates	 of	 the	APC/C	 are	 listed	 in	Table	2.	 The	APC/CCdh1	is	active	primarily	during	late	mitosis	and	through	the	G1	phase	of	the	cell	cycle,	and	one	of	its	primary	targets	during	late	G1	is	polo-like	kinase	1	(Plk1)	(Engelbert	et	al.,	2008;	Fukushima	et	al.,	2013).	The	APC/CCdh1	prevents	premature	S	phase	entry	in	late	G1	by	ubiquitinating	Plk1,	targeting	it	for	proteolysis.	There	is	another	layer	of	regulation	for	Plk1,	in	that	it	is	also	regulated	transcriptionally	(Martin	&	Strebhardt,	2006).	This	double-layered	 regulation	 of	 Plk1	 is	 important,	 as	 it	 is	 responsible	 for	 the	 phosphorylation-dependent	 degradation	 of	 Cdh1	 for	 degradation	 by	 the	 SCF,	 another	 E3	 ubiquitin	 ligase	(Fukushima	et	al.,	2013).	Whole	cell	lysates	from	G0-synchronized	NMuMG	and	E1KD	cells	were	 assayed	 by	 immunoblot	 to	 investigate	 the	 levels	 of	 Plk1.	 G0-synchronized	 lysates	were	utilized	here	in	order	to	encompass	a	larger	proportion	of	the	cell	cycle	than	double	thymidine	block	allows,	including	early	and	late	G1	phase	during	which	APC/CCdh1	is	active.	Levels	of	Plk1	are	markedly	increased	in	the	E1KD	cells	in	late	G1,	suggesting	stabilization	of	the	protein	and	possibly	decreased	function	of	the	APC/C	Cdh1	(Fig.	9).	Expression	of	Plk1	transcript	were	assayed	and	found	to	be	the	same	between	NMuMG	and	E1KD	cells	(data	
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not	shown).	The	mechanism	by	which	APC/CCdc20	targets	Cyclin	A	has	been	debated	(Brito	&	 Rieder,	 2006;	 Izawa	 &	 Pines,	 2011;	 Kramer	 et	 al.,	 2000;	 Prosser	 et	 al.,	 2012),	 and	 its	expression	 is	 consistent	 in	NMuMG	and	E1KDs	(Fig.	9).	Expression	of	 securin,	a	 target	of	APC/CCdc20,	is	largely	diminished	in	E1KD	cells	compared	to	NMuMGs,	suggesting	possible	hyperactivation	 of	 the	 APC/CCdc20	 in	 these	 cells	 (Fig.	 9).	 Securin	 functions	 to	 bind	 and	sequester	 the	 enzyme	 separase,	 preventing	 separase-mediated	 cleavage	 of	 cohesin	 rings	that	tether	sister	chromatids	together	at	the	metaphase	plate	prior	to	anaphase.	After	the	mitotic	 checkpoint	 has	 been	 satisfied	 and	 inactivated,	 the	 APC/CCdc20	 is	 activated	 and	ubiquitinates	 securin,	 causing	 the	 release	 of	 separase	 and	 the	 subsequent	 initiation	 of	anaphase	(Izawa	&	Pines,	2011;	Peters,	2002;	Visintin	et	al.,	1997).	The	stabilization	of	an	APC/CCdh1	substrate	and	loss	of	an	APC/CCdc20	substrate	in	E1KDs	indicated	that	the	activity	of	the	APC/C	might	be	deregulated.			
APC/CCdh1 Substrates APC/CCdc20 Substrates 
Plk1, Skp2, aurora kinases,  
Cdc20, geminin, Cyclin A 
Cyclin B, securin 
 
Table 4: Cofactor-specific APC/C substrates 
 To	 assess	 the	 expression	 levels	 of	 the	 cofactors	 Cdc20	 and	 Cdh1,	 immunoblot	analysis	was	performed	on	whole	cell	lysates	of	G0-synchronized	NMuMG	and	E1KDs.		The	results	showed	that,	while	Cdc20	expression	was	high	throughout	the	cell	cycle	in	E1KDs,	Cdh1	 expression	 was	 almost	 completely	 absent	 (Fig.	 10A).	 The	 absence	 of	 Cdh1	 could	explain	 the	 stabilization	 of	 the	 APC/CCdh1	 substrate,	 Plk1.	 Furthermore,	 the	 increased	expression	of	Cdc20	could	explain	the	destabilization	of	APC/CCdc20	substrate,	securin.	This	
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result	was	interesting,	because	others	have	shown	that	Cdh1	is	necessary	for	maintenance	of	 chromosomal	 integrity	 and	 is	 a	 putative	 tumor	 suppressor	 (Engelbert	 et	 al.,	 2008;	Fukushima	et	al.,	2013;	Garcia-Higuera	et	al.,	2008;	Listovsky	&	Sale,	2013).	Because	Cdh1	had	been	shown	to	be	an	important	contributor	to	chromosomal	integrity	and	prevention	of	unscheduled	proliferation,	we	wanted	to	further	investigate	the	mechanism	by	which	its	expression	 was	 lost	 in	 E1KDs.	 The	 expression	 of	 Fzr1	 at	 the	 mRNA	 level	 remained	unchanged	 between	 NMuMG	 and	 E1KD	 cells	 (Fig.	 10B),	 suggesting	 that	 its	 decreased	expression	occurred	post-transcriptionally.	Furthermore,	polysome	profile	analysis	of	Fzr1	indicated	 that	 its	mRNA	was	 being	 translated,	 as	 it	 sedimented	 to	 polysome	 fractions	 in	both	NMuMG	and	E1KD	cells	(Fig.	10C).	This	result	provided	evidence	that	Fzr1	was	being	transcribed	 and	 translated,	 and	 so	 suggested	 that	 the	 decreased	 expression	 observed	 in	E1KD	cells	could	be	due	to	 increased	degradation.	The	proteasomal	 inhibitor	MG132	was	used	 to	 ascertain	 whether	 proteasomal	 degradation	 was	 responsible	 for	 the	 decreased	levels	of	Cdh1	 in	E1KDs.	MG132	 is	a	peptide	aldehyde	 that	prevents	 the	26S	proteasome	from	 degrading	 ubiquitinated	 proteins	 (Lee	 &	 Goldberg,	 1998).	 Cdh1	 expression	 was	increased	slightly	in	NMuMG	and	increased	markedly	E1KD	cells	treated	for	1	hour	with	10	
µM	 MG132	 (Fig.	 11).	 The	 rescue	 of	 Cdh1	 protein	 in	 E1KDs	 in	 the	 presence	 of	 MG132	provided	 evidence	 that	 proteasomal	 degradation	 was	 eliminating	 the	 transcribed	 and	translated	Cdh1	in	the	cells.		Proteasome-mediated	 degradation	 of	 Cdh1	 occurs	 normally	 during	 the	 cell	 cycle.	Near	the	end	of	G1	phase,	Cdh1	is	sequentially	phosphorylated	by	cyclin	dependent	kinase	2	 and	 then	 Plk1,	 resulting	 in	 its	 release	 from	 the	 APC/C	 core	 complex	 and	 subsequent	recognition	by	the	SCF,	another	E3	ubiquitin	ligase	(Fukushima	et	al.,	2013).	Ubiquitinated	
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Cdh1	 is	 the	 recognized	 by	 the	 26S	 proteasome	 and	 degraded.	 We	 were	 interested	 in	determining	 whether	 the	 activity	 of	 the	 SCF	 was	 modulated	 in	 E1KDs,	 thus	 potentially	resulting	 in	 increased	 ubiquitination	 and	 degradation	 of	 Cdh1.	 The	 SCF,	 much	 like	 the	APC/C,	regulates	its	specificity	by	the	presence	of	a	cofactor:	β-TRCP	or	Skp2	(Benmaamar	&	Pagano,	2005;	Fukushima	et	al.,	2013;	Kurland	&	Tansey,	2004).	The	SCFβ-TRCP	specifically	recognizes	 phosphorylated	 Cdh1,	 ubiquitinating	 it	 and	 tagging	 it	 for	 proteasomal	destruction	 (Benmaamar	 &	 Pagano,	 2005;	 Fukushima	 et	 al.,	 2013).	 To	 assess	 SCF	functionality,	 levels	 of	 substrate-specific	 SCF	 substrates	 were	 analyzed	 in	 NMuMG	 and	E1KDs.	Immunoblot	analysis	showed	that	the	SCFβ-TRCP	substrate	β-catenin	was	increased	in	E1KDs	 (Fig.	 12).	 Importantly,	 this	 evidence	 implies	 that	 activity	 of	 the	 SCFβ-TRCP	 is	 not	enhanced	 in	E1KDs	with	regard	 to	other	substrates,	potentially	 ruling	out	 the	SCF	as	 the	responsible	 party	 in	 Cdh1	 degradation.	 The	 observed	 increase	 in	 β-catenin	 could	 be	 a	result	 of	 increased	 Wnt	 signaling	 in	 E1KD	 cells.	 The	 SCFSkp2	 substrate	 p27	 was	 also	increased	in	E1KDs	(Fig.	12).	This	result	was	not	initially	expected,	since	p27	functions	as	an	 inhibitor	 of	 the	 cell	 cycle,	 however	 recently	 it	 has	 been	 shown	 that	 p27	 can	 function	dually	 as	 both	 an	 inhibitor	 and	 promoter	 of	 CDK	 function	 (Chu,	 Hengst,	 &	 Slingerland,	2008;	Moller,	2000).	Nevertheless,	the	increase	in	p27	expression	indicates	that	SCFSkp2	E3	ligase	 activity	 is	 also	 not	 increased	 in	E1KDs.	 The	 expression	 levels	 of	β-TRCP	 and	 Skp2	were	 also	 assessed	 in	 NMuMG	 and	 E1KD	 cells,	 revealing	 decreased	 levels	 of	 both	 SCF	cofactors	 (Fig.	 12).	 The	 previously	 found	 increases	 in	 β-catenin	 and	 p27	 expression	 in	E1KDs	 may	 result	 from	 this	 decrease	 in	 levels	 of	 SCF	 cofactors.	 While	 this	 result	 was	interesting,	 it	 could	 not	 explain	 the	 increase	 in	 Cdh1	 degradation.	 If	 the	 SCFβTRCP	 was	constitutively	active,	one	would	expect	its	other	substrates	to	be	degraded	as	well.	To	this	
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point,	 the	 results	 suggest	 that	 Cdh1	 is	 being	 proteasomally	 degraded	 in	 E1KDs	 and	 that	increased	 SCFβTRCP	 activity	 was	 not	 responsible.	 We	 considered	 another	 potential	explanation	 for	 increased	 Cdh1	 degradation	 in	 E1KDs:	 constitutive	 phosphorylation	 of	Cdh1	by	Plk1.	This	was	an	attractive	explanation	since	Plk1,	one	of	the	kinases	responsible	for	Cdh1	phosphorylation	and	subsequent	ubiquitination	by	 the	SCF,	was	 found	 to	be	up	regulated	in	E1KDs.	However,	Plk1	is	absent	in	early	G1	in	both	NMuMGs	and	E1KDs	(Fig.	9).	 If	Plk1-mediated	phosphorylation	of	Cdh1	were	responsible	 for	 its	ubiquitination	and	degradation	in	E1KDs,	we	would	still	expect	to	detect	Cdh1	during	early	G1	when	Plk1	is	absent.	This	is	not	the	case,	further	suggesting	that	Cdh1	degradation	in	E1KDs	is	not	due	to	increased	Plk1	phosphorylation.			 Earlier	 experiments	 suggested	 that	 the	 APC/CCdc20	 was	 prematurely	 activated	 in	E1KDs,	 as	 evidenced	 by	 the	 lack	 of	 securin	 expression	 (Fig.	 9).	We	 hypothesized	 that	 a	constitutively	 active	 APC/CCdc20	 could	 ubiquitinate	 and	 degrade	 Cdh1.	 APC/C-mediated	Cdh1	degradation	has	been	reported	previously,	however	 it	was	 reported	 that	APC/CCdh1	self-ubiquitinates	Cdh1	(Listovsky	et	al.,	2004;	Pfleger	&	Kirschner,	2000).	It	has	not	been	shown	 previously	 that	 APC/CCdc20	 recognizes	 and	 ubiquitinates	 Cdh1.	 In	 order	 to	investigate	 the	 contribution	 of	 the	 APC/C	 to	 Cdh1	 degradation	 in	 E1KDs,	 the	 APC/C	inhibitor	proTAME	was	used.	ProTAME	is	a	pro-drug	that	is	converted	to	its	mature	form,	TAME,	 by	 intracellular	 esterases	 and	 functions	 by	 inhibiting	 activation	 of	 the	 APC/C	 by	either	Cdc20	or	Cdh1	(Zeng	&	King,	2012;	Zeng	et	al.,	2010).	NMuMG	and	E1KD	cells	were	treated	 with	 proTAME	 for	 up	 to	 6	 hours	 and	 a	 slight	 increase	 in	 Cdh1	 protein	 can	 be	observed	in	NMuMGs,	while	a	more	obvious	increase	is	seen	in	E1KDs	(Fig.	13A).	The	level	of	Cdh1	is	decreased	in	both	NMuMG	and	E1KD	cells	at	6	hours,	however	we	believe	that	
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this	 is	due	to	cytotoxicity,	as	the	 level	of	Hsp90,	used	as	a	protein	 loading	control,	 is	also	decreasing	with	proTAME	treatment.	These	results	indicate	that,	since	inhibition	of	APC/C	in	 E1KDs	 resulted	 in	 an	 increase	 in	 the	 amount	 of	 Cdh1,	 Cdh1	 is	 being	 targeted	 by	 the	APC/C.	This	could	be	a	direct	result	of	APC/C-mediated	ubiquitin	ligation,	or	the	result	of	stabilization	of	 another	APC/C	 target	 that	protects	Cdh1	 stability.	The	 rescue	of	Cdh1	by	proTAME	 and	 by	 MG132	 both	 occurred	 within	 1	 hour	 of	 treatment,	 suggesting	 that	 an	intermediate	does	not	exist	between	APC/C-mediated	ubiquitination	and	26S	proteasome-mediated	degradation.	However,	the	results	thus	far	could	not	rule	out	an	intermediate	as	a	possibility,	so	the	direct	activity	of	the	APC/C	was	assessed	in	vitro.			 We	performed	in	vitro	ubiquitination	analysis	with	immunopurified	mitotic-	or	G1-APC/C	from	NMuMG	and	E1KD	cells	and	recombinant	substrates.	Cells	were	synchronized	in	mitosis	 using	 thymidine	 block	 followed	 by	 release	 into	 nocodazole.	 After	 12	 hours	 of	incubation	in	nocodazole,	cells	were	released	into	G1.	As	evidence	of	the	activity	of	APC/C	in	normal,	untransformed	cells,	we	showed	that	mitotic-APC/C	from	NMuMGs	was	able	to	ubiquitinate	recombinant	myc-tagged	cyclin	B	 in	vitro	while	G1-APC/C	did	not	(Fig.	13B).	Interestingly,	 both	 mitotic-	 and	 G1-APC/C	 isolated	 from	 E1KD	 cells	 was	 capable	 of	ubiquitinating	 recombinant	myc-tagged	 cyclin	B	 in	vitro	 (Fig.	 13B,	 left	 panel),	 suggesting	that	 the	 APC/CCdc20	 is	 constitutively	 active	 in	 E1KDs.	 This	 observation	 agrees	 with	 the	earlier	 finding	 that	 the	APC/CCdc20	 target,	 securin,	 is	 absent	 in	E1KDs	 throughout	 the	cell	cycle	 (Fig.	 9).	 We	 then	 investigated	 whether	 mitotic	 or	 G1-APC/C	 could	 ubiquitinate	recombinant	GST-Cdh1	in	vitro.	Results	indicate	that	mitotic-APC/C	isolated	from	NMuMG	cells	is	capable	of	ubiquitinating	Cdh1	more	efficiently	than	G1-APC/C	based	on	the	amount	of	shifted	Ub-GST-Cdh1	(Fig.	13B,	right	panel).	Both	mitotic-	and	G1-APC/C	 isolated	 from	
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E1KD	 cells	 ubiquitinate	 GST-Cdh1	with	 approximately	 the	 same	 efficiency,	 based	 on	 the	amount	of	shifted	Ub-GST-Cdh1	in	both	lanes	(Fig.	13B,	right	panel).	Overall,	the	results	of	the	in	vitro	ubiquitination	assays	suggest	two	things:		first,	the	APC/CCdc20	is	constitutively	active	in	E1KD	cells,	and	second,	the	mitotic	APC/C	is	capable	of	ubiquitinating	Cdh1.			 We	 then	wanted	 to	 address	 the	question	of	whether	 excess	Cdc27	 could	 facilitate	premature	 activation	 of	 the	 APC/CCdc20.	 In	 order	 to	 assess	 the	 effect	 of	 Cdc27	 alone,	 a	plasmid	 expressing	 Flag-tagged	 Cdc27	 open	 reading	 frame	 was	 stably	 transfected	 into	NMuMG	cells,	which	we	named	NMuMG-Cdc27.	Immunoblot	analysis	of	Cdc27	expression	in	NMuMG,	E1KD,	and	NMuMG-Cdc27	cells	is	shown	in	Figure	5C.	The	Flag-tagged	Cdc27	is	detected	 at	 a	 slightly	 higher	 molecular	 weight	 than	 endogenous	 Cdc27	 because	 of	 the	additional	weight	of	the	Flag	tag.	GAPDH	is	included	as	a	loading	control	(Fig.	14A).	Next,	we	were	 interested	 in	determining	whether	expressing	Cdc27	alone	 in	NMuMG	cells	was	sufficient	 to	 induce	 degradation	 of	 Cdh1.	 NMuMG,	 E1KD,	 and	 NMuMG-Cdc27	 cells	 were	synchronized	 at	 mitosis	 by	 thymidine-nocodazole	 block,	 then	 released	 into	 G1	 phase.	Blocking	in	mitosis	would	allow	us	to	see	the	activity	of	the	APC/CCdc20,	as	well	as	that	of	the	 APC/CCdh1	 in	 early	 G1	 phase.	 In	 both	 the	 E1KD	 and	 NMuMG-Cdc27	 cells,	 Cdh1	expression	is	not	restored	after	release	from	mitotic	arrest,	whereas	it	does	increase	in	the	NMuMGs	 (Fig.	 14B).	 Immunoblot	 analysis	 also	 included	 levels	 of	 phosphorylated	histone	H3,	a	marker	that	is	commonly	used	to	indicate	presence	in	mitosis.	Based	on	these	results,	it	appears	that	all	 three	cell	 lines	are	able	to	exit	mitosis,	however	 levels	of	Cdh1	are	not	restored	in	the	G1	phase	of	E1KD	or	NMuMG-Cdc27	cells.	Further	analysis	is	necessary	to	validate	 the	 premature	 activation	 of	 the	 APC/CCdc20	 in	 NMuMG-Cdc27	 cells,	 including	 in	
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vitro	ubiquitination	assay	and	analysis	of	the	expression	of	other	APC/C	substrates	such	as	securin	and	Plk1.		According	to	our	results,	Cdc27	expression	is	normally	low	during	the	G1	phase	of	the	 cell	 cycle,	 and	 then	 it	 is	 induced	 after	 the	 G1/S	 transition	 by	 Pak1-mediated	phosphorylation	 of	 hnRNP	 E1.	 This	 increase	 in	 Cdc27	 expression	 coincides	 with	 the	observed	decrease	in	Cdh1	expression,	implying	that	there	may	be	a	relationship	between	increased	 Cdc27	 expression	 and	 decreased	 Cdh1	 expression	 in	 normal	 cells.	 The	 exact	molecular	mechanism	underlying	the	premature	activation	of	the	APC/CCdc20	in	E1KD	cells	remains	 unclear,	 however	 a	 direct	 role	 for	 Cdc27	 is	 suggested	 by	 the	 constitutive	degradation	 of	 Cdh1	 in	 NMuMG-Cdc27	 cells.	 We	 intend	 to	 further	 investigate	 the	contribution	of	 Cdc27	 to	 the	degradation	of	 Cdh1	by	 in	vitro	 ubiquitination	using	APC/C	isolated	from	NMuMG-Cdc27	cells	and	also	Cdc20	knockdown	studies	in	E1KD	cells.		The	anaphase-promoting	complex/cyclosome	is	named	for	its	function	in	promoting	the	 metaphase-to-anaphase	 transition,	 wherein	 cells	 divide	 their	 duplicated	 genetic	material	 prior	 to	 cell	 division.	Premature	 activation	of	 the	APC/C	has	been	 implicated	 in	cancer,	 especially	 in	 the	acquisition	of	aneuploidy	 (Listovsky	&	Sale,	2013;	Prosser	et	al.,	2012).	 One	 consequence	 of	 premature	 activation	 of	 the	 APC/CCdc20	 or	 loss	 of	 Cdh1	 is	 a	decrease	 in	the	percentage	of	cells	present	 in	the	G1	phase	of	 the	cell	cycle,	as	APC/CCdh1	functions	 to	 prevent	 early	 S	 phase	 entry	 under	 normal	 conditions	 (Sigl	 et	 al.,	 2009).	We	investigated	whether	silencing	hnRNP	E1	or	expressing	exogenous	Cdc27	had	an	effect	on	the	 cell	 cycle	 distributions	 of	 NMuMG,	 E1KD,	 NMuMG-Cdc27,	 and	 E1KD-shCdc27	 cells.	E1KD-shCdc27	cells	were	generated	in	the	laboratory	by	lentiviral	shRNA	transduction	and	the	level	of	knockdown	is	shown	by	immunoblot	assay	in	Figure	15A.	GAPDH	is	included	as	
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a	 loading	 control.	 To	 analyze	 cell	 cycle	 distribution,	 propidium	 iodide	 staining	 of	 total	genomic	DNA	was	performed	 in	 fixed	NMuMG,	E1KD,	NMuMG-Cdc27	and	E1KD-shCdc27	cells	 followed	by	 flow	 cytometric	 analysis	 of	DNA	 content.	 The	 percentage	 of	 cells	 in	G1	phase	 in	 E1KD	 and	NMuMG-Cdc27	 populations	 is	 decreased	when	 compared	 to	NMuMG	parental	 cell	 population.	 	 The	 percentage	 of	 E1KD-shCdc27	 population	 in	 G1	 phase	 is	decreased	 compared	 to	 E1KDs	 (Fig.	 15B).	 These	 results	 imply	 that	 hnRNP	 E1,	 through	translational	regulation	of	Cdc27,	plays	a	role	in	maintaining	G1	phase	in	NMuMG	cells.	It	also	strongly	implies	a	role	for	Cdc27	alone	in	maintenance	of	G1	phase.		Premature	 activation	 of	 the	 APC/C	 has	 other	 consequences,	 including	 mitotic	aberrations	 that	 are	 caused	 by	 the	 initiation	 of	 anaphase	 prior	 to	 proper	 chromosomal	alignment	 at	 the	 metaphase	 plate	 and	 microtubule	 attachment	 (Prosser	 et	 al.,	 2012).	Interestingly,	the	percentage	of	cells	present	in	G2/M	in	the	E1KD	and	NMuMG-Cdc27	cell	populations	 was	 found	 to	 be	 increased	 compared	 to	 NMuMG	 cells	 (Fig.	 6B),	 suggesting	G2/M	arrest	or	prolonged	mitoses.	In	order	to	determine	whether	mitotic	aberrations	were	occurring	 in	 cells	 with	 excess	 Cdc27,	 immunocytochemistry	was	 performed	 on	 NMuMG,	E1KD,	and	NMuMG-Cdc27	cells.	Cells	were	 fixed	and	 stained	with	antibodies	 recognizing	alpha-tubulin,	 hnRNP	E1,	 and	DAPI	was	 used	 to	 stain	DNA.	 Confocal	 immunofluorescent	microscopy	 was	 performed	 to	 image	 cells	 in	 various	 stages	 of	 mitosis.	 Representative	images	 are	 shown	 in	 Figure	 16.	 While	 NMuMG	 cells	 underwent	 normal	 mitoses	 with	properly	aligned	 chromosomes	 in	metaphase	and	normal	 anaphases,	E1KD	and	NMuMG-Cdc27	cells	exhibited	several	mitotic	aberrations,	especially	centrosome	amplification	(Fig.	16).	Others	have	shown	that	prolonged	mitotic	arrest	as	a	result	of	loss	of	Cdh1	has	been	implicated	 in	centrosome	amplification	(Anderhub,	Kramer,	&	Maier,	2012;	Prosser	et	al.,	
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2012).	The	total	number	of	mitotic	cells	comprised	a	low	percentage	of	the	total	number	of	cells	 imaged,	 so	 the	 percentage	 of	 cells	 with	 mitotic	 aberrations	 in	 E1KD	 and	 NMuMG-Cdc27	 cells	 was	 not	 statistically	 significant.	 In	 an	 attempt	 to	 increase	 the	 proportion	 of	mitotic	 cells	 in	 each	 cell	 population,	 nocodazole	 was	 used	 and	 unsuccessful,	 since	 its	microtubule-destabilizing	properties	 induced	a	 large	number	of	mitotic	aberrations	 in	all	cells.	 In	 an	 effort	 to	 quantify	 the	 effects	 of	 the	mitotic	 aberrations	 observed	 in	NMuMG-Cdc27	and	E1KD	cells,	metaphase	spreads	were	prepared	and	chromosomes	were	counted.	Representative	images	of	metaphase	spreads	of	NMuMG,	E1KD,	NMuMG-Cdc27,	and	E1KD-shCdc27	 cells	 are	 shown	and	 chromosomes	have	been	 stained	with	DAPI	 (Fig.	 17).	After	counting	 chromosomes	 from	 50	 metaphase-spreads	 each,	 the	 results	 show	 that	 a	significant	 number	 of	 E1KD	 and	 NMuMG-Cdc27	 cells	 exhibited	 aneuploid	 chromosome	numbers	 compared	 to	 NMuMG	 cells	 (P<0.05)	 (Fig.	 17,	 graph).	 Knockdown	 of	 Cdc27	 in	E1KD-shCdc27	 cells	 resulted	 in	 a	 decrease	 in	 aneuploidy	 compared	 to	 E1KD	 cells,	supporting	the	hypothesis	 that	Cdc27	 is	contributing	directly	 to	chromosomal	stability	 in	NMuMG	cells	(Fig.	17,	graph).	This	data	suggests	that	Cdc27	expression	is	directly	related	to	chromosomal	instability,	and	thus	aneuploidy	in	mouse	mammary	epithelial	cells.		To	 study	 the	 process	 through	 which	 cells	 transition	 from	 normal	 to	 highly	metastatic,	we	generated	a	progression	series	of	cell	lines	by	in	vivo	passage	of	E1KD	cells	in	 NOD/SCID	 female	 mice.	 Cells	 that	 tended	 to	 metastasize	 to	 the	 lungs	 following	orthotopic	injection	of	cells	into	the	mammary	fat	pad	were	isolated	and	cultured,	then	re-injected	into	mammary	fat	pads	of	NOD/SCID	female	mice.	This	allowed	for	the	generation	of	 a	 series	 of	 3	 cell	 lines	 in	 addition	 to	 NMuMG	 and	 E1KD,	 termed	M1P,	 L1P,	 and	 L1P.	Figure	 18	 contains	 the	model	 depicting	 the	way	 in	which	M1P,	 L1P,	 and	 L2P	 cells	were	
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generated.	These	cell	 lines	would	 then	be	analyzed	 for	changes	 in	gene	expression,	 in	an	effort	 to	 decipher	 which	 biological	 pathways	 are	 exploited	 by	 metastatic	 cancer	 cells.	Because	 the	 cell	 lines	 originated	 from	 an	 identical	 clone	 (E1KD),	 any	 genetic	 changes	acquired	are	presumed	to	be	a	result	of	the	selective	pressures	of	the	microenvironments	encountered	in	vivo.	Others	have	used	a	similar	method	of	in	vivo	selection	of	cancer	cells	to	generate	cell	 lines	with	organ-specific	metastatic	tendencies	(Bos	et	al.,	2009;	Minn	et	al.,	2005).		The	M1P,	L1P,	and	L2P	cell	 lines	were	characterized	to	assess	their	migratory	and	invasive	capabilities	compared	to	NMuMGs	and	E1KDs.	L1P	and	L2P	cells	were	both	more	migratory	(Fig.	19A)	and	invasive	(Fig.	19B)	 in	vitro	than	E1KD	and	M1P	cells,	suggesting	that	cells	with	increased	migratory	and	invasive	phenotype	are	more	likely	to	metastasize	to	the	lung.	The	ability	of	cells	to	colonize	lung	tissue	was	assessed	by	tail-vein	injection	of	E1KD,	L1P,	and	L2P	cells.	We	hypothesized	that,	given	the	same	amount	of	time	to	colonize	a	 secondary	microenvironment,	 the	more	migratory	 and	 invasive	 cells	 would	 exhibit	 an	enhanced	 ability	 to	 form	 metastatic	 outgrowths.	 Although	 tail-vein	 injection	 does	 not	replicate	all	steps	of	metastasis,	it	is	a	widely-used	practice	to	assess	colonization	potential	(Elkin	 &	 Vlodavsky,	 2001).	 Moreover,	 the	 ability	 of	 E1KD	 cells	 to	 undergo	 all	 steps	 of	metastatic	 progression	had	been	 established,	 as	 L1P	 cells	were	 isolated	 from	E1KD	 cells	that	 had	 invaded	 the	 basement	membrane,	 intravasated,	 survived	 in	 the	 circulation,	 and	extravasated	in	the	lungs	of	mice.	Immunohistological	analysis	of	lungs	of	E1KD,	L1P,	and	L2P-injected	mice	reveal	that	metastatic	outgrowth	is	highest	in	L2P,	followed	by	L1P	and	E1KD	(Fig.	19C).	This	suggests	that	the	L2P	cells,	 in	addition	to	being	the	most	migratory	and	invasive,	also	exhibit	the	best	ability	to	extravasate	and	colonize	lung	tissue.		
 81	
Validation	of	the	identity	of	M1P,	L1P,	and	L2P	cells	was	performed	to	ensure	that	they	indeed	originated	as	E1KD	cells.	Semi-quantitative	RT-PCR	analysis	was	performed	on	total	 RNA	 isolated	 from	 the	 cultured	 cells	 with	 gene	 specific	 primers	 to	 the	 pSilencer	plasmid	 (Fig.	 20).	 E1KD	 cells	 contain	 the	 pSilencer	 plasmid,	 encoding	 for	 an	 shRNA	targeting	hnRNP	E1,	and	NMuMG	cells	do	not.	The	presence	of	pSilencer	gene	in	E1KD,	M1P,	L1P,	and	L2P,	but	not	NMuMG,	provides	evidence	that	the	progression	series	cells	isolated	from	 primary	 tumor	 and	 lung	 metastases	 were	 originally	 E1KD	 cells	 prior	 to	 in	 vivo	passaging.	RT-PCR	analysis	was	also	performed	using	gene	specific	primers	for	Cdc27,	Fzr1,	and	GAPDH	 (control)	 (Fig.	20).	The	 level	of	Cdc27	mRNA	 is	 slightly	 increased	 in	L1P	and	L2P	cells,	whereas	the	decrease	in	Fzr1	mRNA	is	more	obvious	(Fig.	20).	This	data	provides	evidence	that	 the	 loss	of	expression	of	Fzr1	 is	an	adaptation	acquired	by	metastatic	cells,	and	may	play	an	 important	role	 in	metastatic	progression.	The	modest	 increase	 in	Cdc27	expression	may	 be	 explained	 by	 the	 fact	 that	 the	M1P,	 L1P,	 and	 L2P	 cells	 originated	 as	E1KD	 cells,	 where	 we	 have	 shown	 that	 Cdc27	 protein	 expression	 is	 increased	 post-transcriptionally	 as	 a	 result	 of	 loss	 of	 hnRNP	 E1	 binding.	 Without	 hnRNP	 E1,	 a	 further	increase	 in	 Cdc27	 expression	 could	 be	 achieved	 by	 transcriptional	 up-regulation.	Immunoblot	 analysis	 of	whole	 cell	 lysates	 isolated	 from	 the	 progression	 series	 cell	 lines	revealed	a	slight	increase	in	Cdc27	expression	and	a	large	decrease	in	Cdh1	expression	in	the	more	metastatic	 cell	 lines.	This	data	 further	supports	 the	hypothesis	 that	high	Cdc27	and	low	Cdh1	expression	correlate	with	metastatic	potential	in	mouse	mammary	epithelial	cells.			 Cell	 cycle	 profile	 analysis	 was	 performed	 to	 analyze	 the	 distribution	 of	 cell	populations	throughout	the	cell	cycle	in	M1P,	L1P,	and	L2P	cells.	As	mentioned	previously,	
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loss	of	Cdh1	expression	has	been	shown	to	result	in	decreased	G1	populations	(Sigl	et	al.,	2009)	and	increased	G2/M	arrest	(Engelbert	et	al.,	2008;	Garcia-Higuera	et	al.,	2008).	L1P	and	L2P	cells	had	both	larger	G2/M	populations	and	smaller	G1	populations	compared	to	NMuMG,	E1KD,	and	M1P	cell	lines,	suggesting	premature	S	phase	entry	and	mitotic	arrest	(Fig.	 21,	 left).	Metaphase	 spreads	 prepared	 from	M1P,	 L1P,	 and	 L2P	 cells	were	 analyzed	and	average	chromosome	counts	indicate	that	L1P	and	L2P	cells	exhibited	higher	rates	of	aneuploidy	than	E1KD	or	M1P	cells,	suggesting	that	increased	metastatic	potential	is	linked	to	chromosomal	instability	(Fig,	21,	right).	In	the	future,	knockdown	of	Cdc27	in	L2P	cells	will	be	performed,	followed	by	tail-vein	injection	of	L2P	or	L2P-shCdc27	cells.	The	goal	of	this	study	will	be	to	assess	the	impact	of	Cdc27	in	regulating	metastatic	outgrowth.	To	this	point,	 our	 data	 supports	 the	 hypothesis	 that	 Cdc27	 directly	 influences	 chromosomal	stability.	We	hypothesize	that,	by	reducing	expression	of	Cdc27	in	L2P	cells,	their	levels	of	chromosomal	 instability	 will	 be	 reduced,	 decreasing	 adaptability	 in	 changing	microenvironments	and	so	their	metastatic	potential	will	be	attenuated.		Next,	we	were	interested	in	determining	whether	these	results	translated	to	human	disease.	 Since	 NMuMG	 cells	 are	 a	 normal	 mouse	 mammary	 gland	 cell	 line,	 we	 were	interested	in	investigating	the	contribution	of	Cdc27	to	human	breast	cancer.	We	analyzed	several	breast	cancer	cell	 lines	for	Cdc27	expression	as	well	as	cell	cycle	distribution	and	aneuploidy.	 The	HMLE	 cell	 line	was	utilized,	 as	 it	 is	 a	 normal	 human	mammary	 cell	 line	comprised	 of	 two	 separate	 subpopulations:	 	 an	 epithelial-like	 subpopulation	 (HMLE-epithelial)	 that	 exhibits	 characteristics	 of	 differentiated	 epithelial	 cells,	 and	 a	mesenchymal-like	 subpopulation	 (HMLE-mesenchymal)	 that	 exhibits	 some	 stem-like	properties	that	have	been	implicated	in	metastatic	progression	(Mani	et	al.,	2008).	HnRNP	
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E1	was	also	stably	knocked	down	by	 lentiviral	 transduction	of	shRNA	in	HMLE-epithelial	cells	 in	 the	 laboratory	and	named	HMLE-E1KD	cells.	MCF-7,	MDA-MB-231,	MDA-MB-468,	T47D,	 and	 BT20	 breast	 cancer	 cell	 lines	 were	 also	 assayed	 for	 Cdc27	 expression.	Immunoblot	analysis	revealed	an	increase	in	Cdc27	expression	in	the	HMLE-mesenchymal	and	HMLE-E1KD	cells	compared	to	their	epithelial	counterpart,	as	well	as	high	expression	in	MCF-7	and	MDA-MB-231	breast	cancer	cell	lines	(Fig.	22).	Unfortunately,	this	increased	expression	of	Cdc27	did	not	consistently	inversely	correlate	with	expression	of	Cdh1	in	the	breast	 cancer	 cell	 lines,	 suggesting	 that	 the	 mechanisms	 regulating	 Cdh1	 degradation	previously	 supported	 by	 studies	 performed	 in	 NMuMG	 cells	 is	 more	 complex	 in	 human	cells.	GAPDH	was	included	as	a	loading	control	(Fig.	22).		Flow	 cytometric	 analysis	 of	 the	 breast	 cancer	 cell	 lines	 revealed	 a	 decreased	 G1	phase	in	the	same	cell	lines	that	exhibited	highest	expression	of	Cdc27	(Fig.	23).	This	data	implies	 that	 high	 Cdc27	may	 be	 involved	 in	 premature	 S	 phase	 entry,	 a	 consequence	 of	aberrant	APC/C	function.	Furthermore,	the	cell	 line	with	the	highest	expression	of	Cdc27,	MDA-MB-231	 cells,	 exhibited	 the	 largest	 percentage	 of	 cells	 in	 G2/M	 (Fig.	 23).	 Confocal	microscopy	 of	 mitoses	 of	 MDA-MB-231	 cells,	 as	 well	 as	 MCF-7	 cells,	 would	 provide	interesting	evidence	 to	 support	 the	correlation	between	high	Cdc27	and	 the	 incidence	of	mitotic	aberrations.		Many	breast	cancer	cell	lines	exhibit	polyploid	chromosome	numbers,	and	we	were	interested	in	determining	whether	the	level	of	Cdc27	expression	correlated	with	increased	aneuploidy.	 Aneuploidy	 in	 normal	 cells	 results	 in	 cell	 cycle	 arrest	 and	 eventual	 DNA	damage	repair	or	cell	death,	however	cancer	cells	exploit	their	 increased	susceptibility	to	chromosomal	 instability.	 Tumor	 cells	 experiencing	 a	 gain	 in	 copies	 of	 tumor	 promoting	
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genes	 and	 loss	 of	 tumor	 suppressor	 genes	have	 a	 selective	 advantage,	 and	 so	proliferate	and	progress.	Furthermore,	the	ability	to	adapt	to	new	microenvironments	is	facilitated	by	chromosomal	 instability	 (Hanahan	 &	 Weinberg,	 2000,	 2011).	 Metaphase	 spreads	 were	prepared	 from	 breast	 cancer	 cell	 lines	 and	 35	 metaphases	 each	 were	 counted.	 HMLE-epithelial	 cells	 were	 nearly	 all	 diploid,	 with	 46	 chromosomes	 apiece,	 while	 HMLE-mesenchymal	 cells	 consistently	 exhibited	 a	 loss	 of	 one	 or	 two	 chromosomes	 (Fig.	 24),	similar	 to	 HMLE-E1KD	 cells.	 These	 results	 indicate	 that	 cells	 with	 a	 more	 invasive,	metastatic	phenotype	are	susceptible	to	increased	variability	in	chromosome	number.	The	difference	 in	 average	 chromosome	 number	 between	 HMLE-epithelial	 and	 HMLE-mesenchymal	 cells	 was	 significant	 (P	 <	 0.05).	 MCF-7,	 BT20,	 and	 T47D	 cell	 lines	 all	 had	chromosome	 numbers	 around	 3n,	 while	 MDA-MB-231	 and	 MDA-MB-468	 cells	 had	chromosome	 numbers	 over	 2n	 (Fig.	 24,	 graph).	 There	 was	 not	 an	 obvious	 relationship	between	the	level	of	expression	of	Cdc27	and	polyploidy	among	the	breast	cancer	cell	lines,	however	 polyploidy	 was	 prevalent	 in	 the	 cell	 lines	 with	 the	 highest	 Cdc27	 expression	(MCF-7,	 MDA-MB-231,	 and	 T47D).	 The	 relationship	 between	 Cdc27	 expression	 and	chromosomal	 instability	 is	 not	 clear	 at	 this	 point	 in	 human	 cells,	 however	 the	 flow	cytometry	 results	 suggest	 that	 there	may	be	a	 relationship	between	Cdc27	and	cell	 cycle	progression	in	breast	cancer	cell	lines.	Knockdown	studies	would	provide	further	clues	as	to	the	contribution	of	Cdc27	to	the	polyploidy	observed	in	these	cell	lines.		Finally,	breast	cancer	patient	samples	were	acquired	to	assess	Cdc27	expression	in	normal	versus	tumor	tissue.	Tissue	microarray	analysis	of	Cdc27	expression	in	32	matched	patient	samples	revealed	that	Cdc27	expression	is	increased	significantly	in	tumor	samples	compared	to	normal	breast	 tissue	(P	<	0.001)	(Fig.	25A).	Tumor	tissue	staining	was	then	
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scored	to	assign	a	“high”	or	“low”	value	to	samples	(Fig.	25B),	and	patient	survival	data	was	analyzed	 for	 correlation	 between	 staining	 score	 and	 recurrence.	 High	 Cdc27	 staining	predicted	poor	metastasis-free	survival	 in	breast	cancer	patients	compared	 to	 low	Cdc27	staining	 (Fig.	 25B)	 (Log	 rank	 P	 <0.05).	 Cdc27	 has	 not	 been	 shown	 previously	 to	 be	 a	biomarker	 for	 poor	 prognosis	 in	 breast	 cancer,	 but	 our	 results	 indicate	 that	 increased	Cdc27	 expression	 in	 tumors	 could	 predict	 metastasis.	 We	 suggest	 that	 this	 is	 because	increased	Cdc27	expression	is	driving	cell	cycle	progression	in	the	presence	of	a	damaged	or	aneuploid	genome,	and	 this	 increased	susceptibility	 to	chromosomal	 instability	allows	for	cells	to	adapt	to	variable	microenvironments	during	the	process	of	metastasis.		The	 contribution	 of	 Cdh1	degradation	 in	 human	breast	 cancer	 is	 not	 clear,	 as	 the	pattern	expression	of	Cdh1	was	similar	to	that	of	Cdc27	in	tissue	microarray	patient	tumor	samples.	 Cdh1	 staining	 was	 significantly	 higher	 in	 tumor	 samples	 compared	 to	 normal	tissue	(P	<	0.001)	(Fig.	26).	This	data	suggests	that,	while	expression	of	Cdc27	significantly	predicts	 metastatic	 recurrence	 in	 breast	 cancer,	 it	 does	 not	 appear	 to	 correlate	 with	reduction	of	Cdh1	in	the	primary	tumor.	However,	in	tumor	lymph	node	samples,	5	out	of	6	of	those	with	low	Cdh1	score	experienced	disease	recurrence,	while	only	2	out	of	8	of	those	with	 high	 Cdh1	 score	 experienced	 recurrence	 (Fig.	 27A,	 B;	 Table	 4).	 This	 suggests	 that	Cdh1	may	yet	play	a	role	in	the	metastatic	progression	of	breast	cancer,	and	its	significance	will	 be	 clearer	 in	 a	 larger	 sample	 size.	 The	 availability	 of	 metastatic	 lymph	 node	 tissue	presents	a	unique	advantage	over	studying	cancer	cell	lines	in	vitro	in	that	the	expression	levels	 of	 proteins	 can	 be	 obtained	 during	 distinct	 stages	 of	 disease	 progression	 for	comparison.	Furthermore,	maintaining	cell	lines	in	culture	over	several	passages	does	not	accurately	imitate	the	condition	that	cells	face	 in	vivo.	For	this	reason,	we	submit	that	the	
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data	 obtained	 from	breast	 cancer	 patients	 holds	more	 clinical	 relevance	 than	 that	 of	 the	cancer	cell	lines.				
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VI.		Chapter	6:		Conclusions		 The	results	of	 this	study	 lead	us	 to	conclude	that	 the	RNA-binding	protein,	hnRNP	E1,	 regulates	 translation	of	mRNAs	 involved	 in	biological	processes	besides	epithelial-to-mesenchymal	transition.	HnRNP	E1	is	responsible	for	regulation	of	Cdc27	expression	at	the	translational	 level,	 as	 is	 evidenced	 by	 assessment	 of	 total	mRNA,	 protein,	 and	 polysome	profiling	 of	 Cdc27	 expression.	 Cdc27	 translation	 is	 regulated	 in	 a	 cell	 cycle-dependent	manner,	 increasing	 at	 the	 protein	 level	 shortly	 after	 the	 G1/S	 transition,	 but	 not	 at	 the	transcript	level.	We	identify	Pak1	as	the	kinase	responsible	for	phosphorylation	of	hnRNP	E1	at	threonine	60	and	threonine	127	in	vitro.	The	Pak1-specific	inhibitor,	IPA-3,	prevents	the	translation	of	Cdc27	in	the	presence	of	hnRNP	E1.	In	the	absence	of	hnRNP	E1,	Cdc27	is	constitutively	expressed.	Furthermore,	IPA-3	prevents	the	phosphorylation	of	hnRNP	E1	in	
vivo.	 Phospho-mutant	 GST-hnRNP	 E1	 is	 not	 phosphorylated	 by	 Pak1	 in	 vitro,	 further	supporting	the	finding	that	T60	and	T127	are	the	Pak1-specific	phosphorylation	sites.	The	role	 of	 hnRNP	 E1	 in	 translational	 repression	 of	 mRNAs	 involved	 in	 several	 biological	pathways	indicates	that	it	acts	as	a	master	regulator	of	cellular	homeostasis.				 The	consequences	of	silencing	hnRNP	expression	or	constitutive	Cdc27	expression	include	a	decrease	in	the	level	of	APC/C	cofactor,	Cdh1.	Previously,	we	have	shown	that	loss	of	 Cdh1	 expression	 results	 in	 stabilization	 of	APC/CCdh1	 substrates	 and	destabilization	 of	APC/CCdc20	substrates.	The	next	step	in	assessing	the	role	of	Cdc27	in	APC/C	activity	would	be	to	interrogate	APC/C	substrates	in	the	NMuMG-Cdc27	cell	line.	We	predict	that,	due	to	the	 observed	 loss	 of	 Cdh1	 expression,	 APC/CCdh1	 substrates	will	 be	 stable	 in	 these	 cells.	Inhibition	of	 the	proteasome	using	MG132	rescues	Cdh1	 levels	 in	E1KDs,	 suggesting	 that	proteasomal	 degradation	 is	 responsible	 for	 decreased	 levels	 observed	 in	 E1KD	 cells.	We	
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show	that	the	mitotic	APC/C	is	constitutively	active	in	E1KD	cells,	and	that	it	is	capable	of	ubiquitinating	recombinant	GST-Cdh1	in	vitro.	We	show	that	overexpression	of	Flag-tagged	Cdc27	 alone	 is	 sufficient	 to	 cause	 a	 decrease	 in	 Cdh1	 expression.	 Further	 studies	 are	necessary	to	elucidate	the	mechanism	responsible	for	Cdc27-mediated	Cdh1	degradation.			 Silencing	 expression	 of	 Cdc27	 in	E1KD	 cells	 results	 in	 a	 lower	percentage	 of	 cells	present	 in	 mitosis,	 suggesting	 a	 decrease	 in	 G2/M	 arrest	 that	 is	 observed	 in	 E1KD	 and	NMuMG-Cdc27	cells.	Since	modulating	Cdc27	expression	impacts	the	distribution	of	cells	in	the	cell	cycle,	a	direct	role	for	Cdc27	in	regulating	cell	cycle	is	inferred.	Immunofluorescent	confocal	microscopy	of	E1KD-shCdc27	cells	 is	necessary	 to	 further	 investigate	 this	 claim.	Mitotic	aberrations	are	evidenced	by	immunofluorescent	confocal	microscopy	in	E1KD	and	NMuMG-Cdc27	 cells,	 suggesting	 the	 direct	 role	 of	 increased	 Cdc27	 expression	 in	 the	deregulation	of	mitosis.			 Analysis	of	the	E1KD	progression	series	of	cells	concluded	that	more	invasive	cells	express	moderately	higher	amounts	of	Cdc27	protein,	while	expressing	substantially	lower	amounts	of	Cdh1	protein.	These	changes	in	expression	are	reflected	at	the	transcriptional	level,	 suggesting	 that	 they	 are	 the	 result	 of	 genetic	 changes	 experienced	by	 cells	 as	 they	face	 selective	 pressures	 in	 vivo.	 The	 more	 invasive	 cells	 also	 exhibit	 higher	 rates	 of	aneuploidy,	 suggesting	 that	 chromosomal	 instability	 is	 an	 adaptation	 that	 evolves	 as	 a	result	of	in	vivo	selection.	Future	studies	will	include	knockdown	of	Cdc27	expression	in	the	L2P	cell	line	to	assay	metastatic	potential	in	vitro	and	in	vivo.			 Studies	 in	 human	 breast	 cancer	 cell	 lines	 revealed	 that	 Cdc27	 expression	 did	 not	consistently	inversely	correlate	with	Cdh1	expression.	Cdc27	expression	was	lowest	in	the	most	 epithelial-like	 breast	 cancer	 cell	 lines,	while	 Cdh1	was	 highest	 in	 these,	 suggesting	
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that	 their	 expression	 levels	may	 play	 a	 role	 in	 the	maintenance	 of	 epithelial	 phenotype.	High	Cdc27	expression	in	breast	cancer	cell	 lines	positively	correlated	with	mitotic	index.	In	3	of	5	breast	cancer	cell	lines,	aneuploidy	positively	correlated	with	expression	of	Cdc27.	These	 results	 suggested	 a	 correlation	 between	 high	 Cdc27	 expression	 and	 chromosomal	instability.			 Finally,	 tissue	microarray	analysis	reveals	significantly	higher	expression	of	Cdc27	in	breast	cancer	patient	tumor	samples	compared	to	normal	tissue.	Kaplan	Meier	survival	analysis	 reveals	 that	 high	 expression	 of	 Cdc27	 significantly	 predicts	 disease	 recurrence.	While	 Cdh1	 expression	 in	 tumors	 remained	 high,	 expression	 in	 tumor	 lymph	 nodes	 of	patients	experiencing	disease	recurrence	was	low	in	5	of	6	patients.	This	data	suggests	that	Cdc27	 expression	may	 represent	 a	 novel	 biomarker	 that	 predicts	 patient	 prognosis.	 The	data	also	suggests	that	more	aggressive	cases	of	breast	cancer	may	correlate	with	a	loss	of	Cdh1	 expression.	 In	 the	 future,	 I	 intend	 to	 expand	 the	 tissue	 microarray	 analysis	 to	encompass	a	larger	number	of	patient	samples,	as	well	as	other	cancer	types.	In	doing	so,	we	may	find	a	relationship	between	metastatic	propensity	and	Cdh1	expression.		
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Appendix	A		
Buffer	Recipes	RIPA	lysis	buffer	50	mM	Tris	pH	8.0,	150	mM	sodium	chloride	(NaCl),	1%	v/v	NP-40,	0.5%	w/v	sodium	deoxycholate,	0.1%	w/v	sodium	dodecyl	sulfate	(SDS)	Laemmli	sample	buffer			60	mM	Tris-Cl	pH	6.8,	2%	w/v	SDS,	0.01%	w/v	bromophenol	blue,	5%	v/v	β-mercaptoethanol,	10%	glycerol	Kinase	assay	lysis	buffer	50	mM	Tris	pH	8.0,	150	mM	NaCl,	10%	glycerol,	1%	Tween-20,	1	mM	sodium	fluoride	(NaF),	1	mM	sodium	orthovanadate	(Na3VO4),	1	mM	dithiothretiol	(DTT),	50	mM	β-glycerophosphate	Kinase	reaction	buffer	10	mM	HEPES	pH	7.5,	50	mM	NaCl,	10	mM	MgCl2,	1	mM	DTT,	50	mM	β-glycerophosphate	Tris-buffered	saline	with	Tween-20	(TBS-T)		 20	mM	Tris	pH	7.6,	150	mM	NaCl,	0.1%	Tween-20	S100	lysis	buffer	20	mM	Tris	pH	7.4,	10	mM	KCl,	1.5	mM	MgCl2,	1	mM	ethylene	glycol	tetraacetic	acid	(EGTA),	1	mM	ethylenediaminetetraacetic	acid	(EDTA),	1	mM	DTT,	protease	inhibitors	
In	vitro	ubiquitination	lysis	buffer		 1X	Phosphate	buffered	saline,	1%	v/v	NP-40,	0.5%	v/v	glycerol	
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Ubiquitination	reaction	buffer	10	mM	Tris-Cl	pH	7.6,	5	mM	magnesium	chloride,	10	mM	dithiothreitol,	1	mg/ml	human	recombinant	ubiquitin,	10	mM	phosphocreatine,	50	µg/ml	creatine	phosphokinase,	15	mM	adenosine	triphosphate,	0.15	mg/ml	bovine	serum	albumin		
